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Wastewater treatment plants (WWTPs) are traditionally designed to target the removal of 
contaminants such as total suspended solids, phosphorous, biological oxygen demand, and 
ammonia.  Recent changes to the Federal Wastewater Systems Effluent Regulations (WSER) in 
Canada require all WWTPs to be operating with secondary treatment or equivalent by 2021.  
Upgrades being implemented at WWTPs across the country will improve the quality of final 
effluent discharged into the receiving waters.  However, over the past several years, 
contaminants of emerging concern such as pharmaceuticals, personal care products, and 
endocrine disrupting compounds have become widely prevalent in wastewater. These 
compounds are not monitored or targets for removal in Canada causing them to be routinely 
discharged into surface waters.  
The Grand River watershed is the largest watershed in southern Ontario and receives 
effluent discharge from 30 WWTPs. Several studies have been conducted in the Grand River to 
assess the impacts of effluent discharge on fish found in the river. The two largest WWTPs are 
the Kitchener and Waterloo WWTPs, both of which having recently undergone upgrades to 
improve nitrification processes and improve the overall effluent quality. Studies linked effluent 
from the plant’s pre-upgrade, to several adverse impacts on fish, such as severe cases of intersex 
and altered hormone production. Upgrades at the Kitchener WWTP were shown to reduce these 
impacts on fish. Effluent from both Waterloo and Kitchener have been collected and analyzed 
for pharmaceuticals and estrogens since before the upgrades providing the unique opportunity to 
evaluate the change in effluent quality and composition over time. In addition to the Kitchener 
and Waterloo WWTPs, nine secondary WWTPs across southern Ontario were studied to 
compare the composition of influent and effluent as well as evaluate the apparent removal of 
various pharmaceuticals and estrogens.   
Despite all the plants being classified as having secondary level treatment there was a 
considerable amount of variability in their ability to treat the incoming influent.  Pharmaceuticals 
of interest were ibuprofen, naproxen, carbamazepine, and venlafaxine because of their different 
behaviour during treatment. Ibuprofen and naproxen were significantly reduced at all plants, with 
an increased reduction at plants achieving better nitrification. Carbamazepine and venlafaxine 
are recalcitrant and remained untreated. Of the estrogens measured, estriol was significantly 
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reduced across all plants while 17α-ethinylestradiol had no difference post treatment. Estrone 
and 17β-estradiol were both reduced to varying degrees and were more influenced by external 
factors such as treatment type and biotransformation. Although there was compound specific 
variability, the total estrogenicity was significantly reduced post treatment at all plants except 
those with poor nitrification. Through the analysis of the pharmaceuticals and estrogens as well 
as nutrient data, nitrification was related to the apparent removal of these non-target compounds 
(although a direct relationship cannot be established). This correlates with the findings at the 
Kitchener and Waterloo WWTPs. With the introduction of nitrification at both plants there was a 
decrease in ammonia concentrations, improved treatment of ibuprofen, naproxen, estrone, and 
estradiol. There was also a decrease in the total estrogenicity of the effluent discharged from the 
plants. While venlafaxine, carbamazepine and ethinylestradiol concentrations remained 
unchanged post upgrades.  
Understanding the composition and concentration of contaminants in influent and 
effluent can provide insight into treatment processes influencing the removal and 
biotransformation of these compounds. This information is important when deciding on the 
regulation of these contaminants in effluent discharge. Chemical analysis of these compounds is 
also critical in developing relationships between contaminant exposure to impacts found in the 
Grand River. This data can aid in validating predictive models linking contaminants to specific 
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Chapter 1 – Introduction  
Municipal wastewater is a major source of surface water contamination in several 
countries (Adeel et al. 2017; EC 2011; Holeton et al. 2011). In Canada, the specific treatment 
regime used in wastewater systems is very site specific and depends on factors such as influent 
characteristics, available infrastructure, required effluent quality, the sensitivity of the receiving 
environment and regulatory requirements (Ramalho 1983). The quality of the treatment can 
therefore be highly variable and effluent released from some plants may be a threat to the 
ecosystems in the receiving environments (Holeton et al. 2011). A growing concern in regards to 
wastewater effluent is the presence of endocrine disrupting compounds (EDCs) which can 
impact fish and other organisms in the environment across multiple levels of biological 
organization (Mills & Chichester 2005; Tyler et al. 1998). Trace levels of EDCs, particularly 
natural and synthetic hormones, have been associated with the alteration of hormone production, 
high incidences of intersex and reproductive success of fish (Kidd et al. 2007; Parrott et al. 2005; 
Andersen et al. 2003; Lange et al. 2001; ). Although it has been documented that trace levels of 
these contaminants are found in final effluent (Servos et al. 2005; Ternes et al. 1999), they are 
difficult to quantitate due to the complexity of the sample matrix and the lack of reliable and 
validated methods to analyze these compounds. This thesis aimed to apply a robust analytical 
method to measure and characterize the concentration of natural and synthetic estrogens in the 
effluents from nine municipal WWTPs from southern Ontario. In addition, the concentrations of 
estrogens in two wastewater treatment plants in the Grand River watershed, that have recently 
undergone major infrastructure upgrades, have been followed over the past 10 years and 
analytical methods were used to explore and understand the fluctuations in concentrations.  
1.1 Municipal Wastewater Treatment 
Municipal wastewater is a complex matrix that originates from many sources including 
residential, commercial, industrial, urban and agricultural inputs. The various sources add a 
diversity of substances such as suspended solids, organic and inorganic contaminants, making 
the composition of raw influent very complex. Although treatment can reduce the presence of 
many of these contaminants, and their transformation products, many are still released into the 
environment in the final effluent (Tran et al. 2018).   
Wastewaters can undergo a variety of different treatment processes that are generally 
classified as pre, primary, secondary, and tertiary treatment (Ramalho 1983). The pretreatment 
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and primary treatment of wastewater involves the removal of suspended solids typically using 
methods such as screening, sedimentation, and flotation. Secondary treatment utilizes biological 
processes to decrease the biological oxygen demand (BOD) and nitrogen levels, often performed 
mechanically using the activated sludge process or passively using other techniques such aerated 
lagoons, or trickling filters. Following secondary treatment, the effluent can enter a tertiary 
treatment system, which is considered advanced treatment and is not as common among 
municipal WWTPs (Ramalho 1983).  This stage of treatment is used to further improve the 
quality of effluent before discharge into the receiving water and employs a diversity of processes 
such as filtration and various forms of advanced oxidation. Finally, depending on the receiving 
environment and season, the final effluent may undergo some form of disinfection (chlorine, UV 
light, etc.) before being released into the environment. Tertiary treatment is often a critical step 
in removing potentially harmful chemicals (e.g. EDCs) and nutrients (such as phosphorous) from 
final effluent to avoid adverse effects in vulnerable aquatic ecosystem. In recent years, additional 
treatment steps such as powdered carbon and ozone, have been introduced to remove specific 
contaminants of concern, such as pharmaceuticals (Eggen et al. 2014).  
1.1.1 Regulations  
In 2009, 80% of wastewater in Canada received at least secondary treatment and 
investment in wastewater has continued nationally (Mavinic et al. 2018; EC 2011). The 
introduction of the federal Wastewater Systems Effluent Regulations in 2012 under the Fisheries 
Act Canada has redirected the focus of municipalities to water quality (Ministry of Justice 2017). 
The new Fisheries Act Regulations on wastewater requires that all municipal wastewater 
treatment plants across Canada operate at a standard of at least secondary treatment or equivalent 
by 2021 to control and improve the quality of discharged effluent and most sites are working 
towards this goal (CCME 2014; Ministry of Justice 2017).    
The regulation specifically targets carbonaceous biochemical oxygen demanding matter 
(CBOD), total suspended solids (TSS), total residual chlorine, and un-ionized ammonia and aims 
to attain the following effluent conditions (Ministry of Justice 2017): 
1. average CBOD in the effluent does not exceed 25 mg/L;  
2. average concentration of TSS does not exceed 25 mg/L;  
3. average concentration of total residual chlorine does not exceed 0.02 mg/L;  
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4. maximum concentration of un-ionized ammonia does not exceed 1.25 mg/L, 
express as nitrogen (N), at 15°C ± 1°C; 
The regulation also requires that the effluent discharged must not be acutely lethal to fish. 
Studies have found that even low concentrations of un-ionized ammonia can be toxic to aquatic 
species (Camargo & Alonso 2006).  
In addition to federal regulations, Ontario treatment plants also need to comply with 
Provincial legislation, including Certificates of Approval (COA) (MOE 2016). The COA sets site 
specific criteria to be met for the release of wastewater for each treatment plant. The Ontario 
Ministry of the Environment Conservation and Parks (OMECP) has established Provincial Water 
Quality Objectives to provide guidelines on how to manage the quality and quantity of surface 
and ground waters (MOEE 1999). The goal is to ensure that the quality of surface water is 
sufficient to maintain aquatic life and recreation. These guidelines entail a much longer list of 
compounds with more specific water quality limits compared to the federal Wastewater Systems 
Effluent Regulations. However, the list does not include contaminants of emerging concern such 
as pharmaceuticals and personal care products (PPCPs) or EDCs. 
Unlike Canada, the European community has introduced environmental quality standards 
(EQS) which is a list of chemicals selected for monitoring and control (Carvalho et al. 2015). 
Estrogenic hormones were recently added to the list in order to collect monitoring data to make 
more informed regulatory decisions. The European Commission has proposed the acceptable 
annual average of 17α-ethinylestradiol and 17β-estradiol in inland surface waters to be 0.035 
ng/L and 0.4 ng/L respectively (European Commission 2011), despite very few methods being 
able to detect concentrations this low. In Canada, these compounds are being monitored under 
various research programs, however there are no regulations for their removal from effluent 
discharges. Despite this, upgrades to WWTPs to meet the new regulations have been found to 
also reduce many microcontaminants (e.g. PPCPs, EDCs) in final effluent (Hicks et al. 2017).   
Considerable research has examined how various treatment processes alter the removal of 
specific microcontaminants, PPCPs and EDCs in effluents (Ben et al. 2017; Joss et al. 2004; 
Johnson & Sumpter 2001). However, the distribution and removal of these contaminants, 
especially environmental estrogens, are poorly understood making them a growing concern 
(Cirja et al. 2008). 
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1.2.1 PPCPs in Wastewater  
The fate of various pharmaceuticals and personal care products during wastewater 
treatment has been widely studied (Tran & Gin 2017; Yang et al. 2011; Kasprzyk-Hordern et al. 
2009; Cirja et al. 2008; Kolpin et al. 2002;). The ability of these compounds to be removed or 
degraded is highly variable and depends heavily on their specific physiochemical properties such 
as structure and solubility (Tran et al. 2018). Research shows that compounds such as 
carbamazepine, diclofenac, and venlafaxine are not susceptible to biological treatment and 
remain very persistent (Tran & Gin 2017; Rua-Comez & Puttmann 2012). Compounds such as 
naproxen and salicylic acid are considered to have moderate removal, whereas compounds like 
ibuprofen, acetaminophen, and caffeine can easily be degraded (Tran & Gin 2017). It is 
suggested that compounds with high hydrophobicity and strong electron donating groups/weak 
electron withdrawing groups can readily undergo biotransformation and adsorb onto biomass. 
Compounds with moderate removal typically have the presence of both electron donating and 
withdrawing groups while persistent compounds have strong electron withdrawing groups/weak 
donating groups, making it much harder to degrade biologically (Tran & Gin 2017).   
1.2.2 EDCs in Wastewater  
EDCs are exogenous compounds that can interfere with natural processes, such as 
hormone biosynthesis, metabolism, and homeostasis (Lister & Van Der Kraak 2001). Estrogenic 
compounds are a potent subset of EDCs due to their high affinity to the estrogen receptor in 
aquatic organisms and therefore their ability to mimic and interfere with normal endocrine 
functions, especially reproduction and development (Gunatilake et al. 2016; Aris et al. 2014).  
Estrogenic compounds have been detected in industrial and municipal effluent, and urban and 
agricultural runoff, where concentrations as low as 5 ng/L have been documented to cause 
feminization of male fish (e.g. intersex) (Gunatilake et al. 2016; Kidd et al. 2007). Feminization 
entails the development of oocytes in testicular tissue (ova-testes), therefore the occurrence of 
intersex fish is likely to have adverse effects on the growth and reproduction of fish (Fuzzen et 
al. 2015; Ankley et al. 2010). Exposure to EDCs found in effluent discharge has been found to 
not only impact fish on an individual level, but also on a larger scale. The exposure of fish to 
effluent discharge has been shown to impact fish communities in terms of their abundance, 
diversity, as well as species and family richness (Tetreault et al. 2012). It has also been found 
that although fish collected near large urban areas and effluent discharge sites had little change in 
fertilization success, there was a reduced survival of the progeny to hatch (Fuzzen et al. 2015). A 
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study has also found that long term exposure to estrogens affects gonad development, resulting 
in the near collapse of a fish population (Kidd et al. 2007). 
Although many chemicals can alter endocrine function in fish, the major estrogens 
responsible for the total estrogenicity of municipal effluent have been identified as natural 
estrogens (17β-estradiol (E2), estriol (E3), estrone (E1)), synthetic estrogens (17α-
ethynylestradiol (EE2)), and alkylphenolic chemicals (Briciu et al. 2009; Desbrow et al. 1998). 
EE2 is a synthetic analog of E2 commonly used in birth control pills, however it has a high 
binding affinity to estrogen receptors and therefore trace concentrations of EE2 in effluent are 
environmentally relevant (Aris et al. 2014). However, natural estrogens are often the most 
dominant estrogens in both the influent and effluent (Ben et al. 2017). 
Estrogens are excreted as glucuronide or sulfate conjugates but are quickly transformed 
to their unconjugated and more bioactive forms once they enter the WWTP collection systems 
(Adeel et al. 2017; Fernandez et al. 2007; Ternes et al. 1999). It was found that the 
transformation of conjugated estrogens begins in the collection system, with rapid cleavage 
occurring in the activated sludge system (Liu et al. 2015; Ternes et al. 1999).  The presence of 
conjugated estrogens complicates interpretation of the analysis as they are not typically included 




Treatment plants implementing nitrification processes, higher temperatures, and longer 
solid (SRT) or hydraulic (HRT) retention times have higher levels of hormone removal and 
decreased estrogenicity (Ben et al. 2017; Servos et al. 2005; Johnson & Sumpter 2001). 
Generally, E3 has the highest removal followed by E2, E1 and EE2 (Ben et al. 2017; Johnson & 
Sumpter 2001). The estrogens can undergo degradation and transformation to other estrogens or 
forms during various treatment processes, as seen in Figure 1.1 (Adeel et al. 2017). Due to the 
hydrophobic properties of EE2, which has a Kow of 3.9-4.1, it is predicted that approximately 80- 
90% of EE2 will bind to sludge and be removed from the final effluent (Johnson & Sumpter 
2001; Joss et al. 2004). However, EE2 still makes a major contribution to the total estrogenicity 
of final effluent, along with the more water soluble natural estrogen (E2, E1, E3) (Desbrow et al. 
1998). Elevated levels of total estrogenicity has been detected in the effluent discharged into the 
Grand River and has been associated with several cases of intersex in the native fish species 
found in this watershed (Arlos et al. 2018; Hicks et al. 2017; Fuzzen et al. 2015).  Effects 
Directed Analysis has suggested that the total estrogenicity (based on the Yeast Estrogen Screen) 
is primarily associate with natural (E2, E1) and synthetic (EE2) estrogens (Arlos et al. 2018). 




Unfortunately, the lack of a validated analytical method at the time prevented confirmation of 
these chemicals in these effluents.   
1.3 Grand River Watershed  
The Grand River watershed covers 6965 km2 of southern Ontario and is the recipient of 
wastewater effluent from 30 different WWTP (Figure 1.2) which all have varying levels of 
wastewater treatment and is also 
strongly influenced by rich agricultural 
lands, and urban developments (Cooke 
2006). The upper Grand River 
watershed generally has good water 
quality due to minimal urban influences 
and the presence of low-intensity 
agriculture, wetlands, and forested lands 
(Cooke 2006). However, moving into 
the middle Grand River there is a 
discernible decrease in water quality 
attributed to the heavy agriculture and 
urban development. Three major 
agricultural tributaries drain into the 
middle Grand River adding to the 
increased levels of phosphorus, total 
ammonia, chloride, and nitrate. The 
lower Grand River receives the 
cumulative impacts from upstream but 
also receives inputs of groundwater that 
improve water quality, although there 
are increased levels of suspended solid as the river flows through the southern clay plain.  
The two major WWTPs along the Grand River are the Kitchener WWTP and the 
Waterloo WWTP, both of which recently completed major upgrades to their infrastructure and 
processes (Bicudo et al. 2016). These plants were initially designed to treat wastewater using a 
conventional activated sludge system and continuous phosphorus removal followed by chlorine 
Figure 1. 4 Grand River Watershed WWTP and 






disinfection to service a population of 138,271 and 54,157 people respectively in 1984 (AECOM 
2012; OMOE 1984). As of 2017, these plants service 219,000 and 98,000 people, respectively. 
Both have undergone major upgrades to implement extended solids retention time, additional 
aeration (nitrification) and UV disinfection to improve the final effluent quality (Bicudo et al. 
2016; AECOM 2012). The upgrades focus on three major issues that include improving effluent 
quality and odour control, decommissioning existing biosolids storage lagoons and improving 
process efficiency, and aim to meet the effluent requirements presented in Table 1.1. 
Table 1.1 WWTP upgrade effluent objectives (Adapted from AECOM 2012; provided by 
Pam Law, Region of Waterloo) 
  Kitchener Waterloo  
  Effluent Limits  
Operating 
Objectives  
Effluent Limits  
Operating 
Objectives  
Parameter Current Future1 Current Future Current Future2 Current Future 
CBOD5 (mg/L) 25 15 15 10 15 15 NA 10 
TSS (mg/L) 25 15 15 10 15 15 NA 10 





- 4  - 2  
- 1.8 NA 1.5 
Dec - 
Apr 
- 7 - 5 
pH 6-9.5 6-9.5 6.5-8.5 6.5-8.5 - 6-9.5 NA 6-9.5 
E. coli (org/100 
mL) 
200 200 100 100 200 200 NA 100 
Total chlorine 
residual (mg/L) 
- - - - 0.5 - NA - 
1. Future limits apply upon substantial completion of Plants 3 and 4 (estimated for early 2019) 
2. Future limits apply upon substantial completion of the current contract (estimated for June 2018) 
3. NA, Not available 
 
In addition to improvements in traditional water quality such as BOD, TSS, chloride and 
ammonia (Hicks et al. 2017; Bicudo et al. 2016; ), a decline in the concentrations of 
pharmaceuticals and total estrogenicity of the final effluents released into the river have been 
observed as the upgrades were implemented (Hicks et al. 2017). Impacts on fish populations 
were very prominent downstream of the outfalls of these plants prior to the upgrades and 
included changes across several levels of biological organization (Fuzzen et al. 2016; Tetreault et 
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al. 2012, 2011). The recent upgrades have led to a major improvement in a number of endpoints 
including occurrence and severity of intersex (Hicks et al. 2017), and in vitro production of 
steroid hormones in fish (Marjan et al. 2018).  These endpoints are suspected to be associated 
with exposure to estrogenic chemicals in the effluent (Bahamonde et al. 2013; Fuzzen et al. 
2015). Arlos et al. (2018) has modelled the fate of estrogenic chemicals in the effluents and river 
and established a relationship between the predicted estrogenicity and endocrine responses (i.e. 
intersex) observed in fish downstream. The accurate quantification of estrogenic compounds in 
the effluent would aid in linking the changes in fish endpoints to the changes in effluent quality 
as well allow for the improvement and validation of model predictions.  
1.4 Analysis of Estrogens in Wastewater 
To characterize the quality of the effluent being discharged by WWTPs two different 
approaches can be taken. Bioassays can be used to measure the total estrogenic potency of the 
effluent or a chemical analysis can be performed to measure the concentrations of the individual 
target analytes (Könemann et al. 2018).  
1.4.1 Biological Analysis  
The total estrogenicity of a sample is a combination of the effects of various EDCs 
working through the same mechanism (i.e. binding to the estrogen receptor). Although there are 
many approaches to measuring estrogenicity (Leusch et al. 2010; Streck 2009; Drewes et al. 
2005) the Yeast Estrogen Screen (YES) is a commonly used tool that is well suited to municipal 
wastewater (Bistan et al 2012; Leusch et al. 2010; Desbrow et al. 1998). The YES assay was 
originally developed by Gaido et al. and has been widely applied to measure total estrogenicity 
of wastewater extracts (Marjan et al. 2018; Sun et al. 2017; Volker et al. 2016), including the 
Grand River wastewater effluents (Hicks et al. 2017).  
The YES assay uses a strain of Saccharomyces cerevisiae transfected with two plasmids. 
The first is an expression plasmid containing the CUP1 metallothionein promoter and the human 
estrogen receptor cDNA. The second is a reporter plasmid containing estrogen response elements 
upstream of the LacZ gene. The growth media of the yeast contains copper to induce the 
production of the estrogen receptors in the yeast cells. When the yeast cells are exposed to 
estrogen, the estrogens bind to the receptors and this complex will bind the estrogen response 
element on the second plasmid, inducing the transcription of the LacZ gene to produce the 
enzyme -galactosidase. The amount of enzyme produced can be measured by introducing the 
colourless substrate ortho-nitrophenolgalactopyranoside (ONPG) and measuring the colour 
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change as the enzyme cleaves ONPG, forming ortho-nitrophenol (ONP), a yellow compound 
over time. The total estrogenicity of the sample can then be indirectly calculated from the change 
in absorbance measured from the colour change in the assay. 
1.4.2 Chemical Analysis  
In addition to measuring total estrogenicity, conducting a chemical analysis on the 
effluent to determine the concentration of the individual analytes provides a better understanding 
of the contribution of the individual compounds to the total estrogenicity.  
Historically estrogen analyses were performed using gas chromatography – mass 
spectrometry (GC-MS), which has good sensitivity and separation of compounds (Petrovic et al. 
2002). However, these compounds are not volatile by nature and require derivatization for 
analysis by GC-MS, leading to sample loss, and interferences that can out-weigh the advantages.  
Recently the analysis of estrogens using liquid chromatography with tandem mass spectrometry 
(LC-MS/MS) with the electrospray ionization (ESI) and atmospheric pressure chemical 
ionization (APCI) interfaces, has increased in popularity due to the sensitivity, ruggedness, ease 
of use and avoiding the need to derivatize the samples.   
LC uses a packed column to retain target analytes that are then eluted from the column in 
a specific order based on the mobile phase solvent composition and chemical properties of the 
analytes (Mikkelsen & Corton 2004). The eluted compounds are then introduced into the ion 
source, either ESI or APCI, of the mass spectrometer. ESI is a technique used to ionize the 
sample by creating very fine charged droplets (Cappiello 2007). APCI relies on gas-phase ions 
and solvent composition to undergo chemical reactions, typically acid-base chemistry, with the 
neutral analytes to form analyte ions (parent ion). ESI is the most commonly used ion source 
because of its low solvent consumption and its ability to ionize a wide variety of analytes. 
However, ESI is much more susceptible to matrix effects compared to APCI. 
  Once ionized, the analyte enters the MS where they are accelerated by an electrical 
potential towards a detector (Mikkelsen & Corton 2004). Due to the differences in charge to 
mass ratio, the ions are separated and focused for detection and quantification of analytes. The 
LC-MS/MS allows for fragmentation of the analyte using the tandem MS, providing increased 
selectivity. The parent ion collides with neutral gas molecules to induce fragmentation. 
Fragmentation is analyte specific and creates a unique mass-to-charge (m/z) ratio which is used 
to sort and detect the analytes, providing quantitative and qualitative data. The LC-MS/MS can 
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be operated under two modes, selected reaction monitoring (SRM) or multiple reaction 
monitoring (MRM) (Murray et al. 2013). SRM is a non-scanning method that uses two specific 
masses as filters to increase selectivity, whereas MRM will cycle through multiple mass 
transitions and measures the signal of all transitions at the different elution times. MRM 
therefore allows the monitoring of different mass transformations for a single analyte, increasing 
the selectivity.  
The capabilities of the instrumentation are measured and reported as limit of detection 
(LOD), limit of quantification (LOQ), and method detection limit (MDL) (Armbruster & Pry 
2008;  Harris 2010). The LOD is the lowest concentration of an analyte that can be identified by 
an analytical instrument, producing a signal 3 times greater than the background (3:1 signal to 
noise ratio) (Armbruster & Pry 2008). The LOQ is the lowest concentration of an analyte that 
can be used to accurately quantify an analyte. This concentration should produce a signal to 
noise ratio of 10:1. The MDL is the minimum concentration of an analyte that can be quantified 
from a sample with a 99% confidence (Harris 2010).  
LC-MS/MS using MRM is much more selective and sensitive than single quadrupole 
instruments and can achieve LODs of less than 1 ng/L, which is comparable to the sensitivity 
achieved using a GC-MS/MS (Petrovic et al. 2002). However, this is dependent on the 
instrument and sample matrix. Further resolution of compounds can be achieved using 
instruments such as an LC-MS/MS quadrupole time-of-flight (QTOF) that can achieve an exact 
mass of 0.001 or greater (Harris 2010). QTOF applies a high voltage to the ions to accelerate 
them through the ion source into a region with no electric or magnetic field. It is here that ions of 
different masses will separate since ideally, they will all have the same kinetic energy but due to 
mass differences the ions will travel at different speeds. The lighter ions will travel faster and 
reach the detector before the heavier ions, therefore this technique is more mass specific. This 
higher selectivity can be helpful when trying to identify compounds in complex samples. 
Using the calculated concentrations of the individual estrogens, an estimate of the total 
estrogenicity can be made by summing the contribution of each of the estrogens present 
(concentration x relative potency to E2) and expressed as an E2 equivalence (EEQ) (Arlos et al. 
2018). The E2 equivalency factor for E1, E2, E3 and EE2 were reported as 0.3, 1.0, 0.03 and 
1.23 respectively based on the YES assay. Ideally, the chemically determined estrogenicity 
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would align with the values determined using the biological assay, however there are many 
limitations to these analyses, as well as discrepancies between the methods.  
1.4.2.1 Mass Fragment Patterns of Estrogens  
Currently, LC-MS/MS is the most commonly used method to quantify specific estrogens 
in influent, effluent, and river water (Briciu et al. 2009). For the analysis of estrogens using mass 
spectrometry, the mass transition producing the most abundant product ion is used to quantify 
the compound, while less abundant but unique product ions are used as qualifiers to confirm the 
identity of the compound (Harris 2010). Natural and synthetic estrogens have very similar 
structures, as a result produce similar product ions (Table 1.2).  

















































  In the case of EE2, the product ion with the mass to charge ratio of 145 is most 
commonly used as the quantifier while 143 or 159 are used as the qualifiers (Magi et al. 2010; 
Vulliet et al. 2008; Croley et al. 2000). The 145 m/z is characteristic of the stable double phenol 
ring found in EE2 and is common among all estrogens and many steriods (Andrási et al. 2011; 
Magi et al. 2010).  
1.4.3 Limitations  
 Despite the advancements made in the analysis of estrogens in effluent samples, there are 
still many analytical challenges to measuring these compounds, specifically E2 and EE2 
(Konemann et al. 2018). A study comparing the analysis of estrogens in wastewater samples by 
various labs found that EE2 could only be quantified above the LOQ in less than 50% of the 
samples (Konemann et al. 2018). Currently the most attainable LOQ is 0.1 ng/L, however at this 
concentration the uncertainty of these results range between 50-100% (Heiss 2013). In addition, 
the highly complex nature of wastewater effluent results in matrix effects which raises the LOQ 
of these compounds, making analysis more difficult. Environmental samples are variable and 
consist of various compounds, such as humic acids, that can cause interferences during analysis 
(Vega-Morales et al. 2013).  These compounds can co-elute with the compounds of interest 
causing ion suppression/enhancement and reduced sensitivity of the detection method (Gomes et 
al. 2005; Petrovic et al. 2002). Estrogens are found at low levels in the environment and the 
susceptibility of the LC-MS/MS to matrix effects makes accurate quantification difficult (Briciu 
et al. 2009).  
To improve the resolution and sensitivity during the separation of the estrogen 
compounds studies have used Ultra-High Performance Liquid Chromatography (UHPLC) 
coupled with a tandem mass spectrometer (Ripolles et al. 2014; Kumar et al. 209). However, 
even with higher resolution, matrix effects can still be a problem. A study on the analysis of 
estrogens in surface water, influent, and effluent using UHPLC found high levels of background 
noise for the most commonly used EE2 transition of 295 m/z to 145 m/z (Ripolles et al. 2014). 
Therefore sample extraction and preparation are critical in the analysis of estrogens. 
A method used to address the presence of matrix effect is standard addition (Harris 
2010). This technique involves the addition of varying concentrations of standard solution to 
replicates of an unknown sample to determine how the matrix influences the signal response. 
The total concentration of analyte from the unknown and standard should increase linearly due to 
14 
 
the added standard. In the absence of matrix effect, the calculated analyte concentration in each 
of the samples will be the same, however, with matrix effect the calculated concentrations for the 
sample will be different. For each concentration added to the sample the amount of matrix effect 
is expected to be consistent, therefore by comparing the original sample to the spiked sample the 
relative amount of matrix effect can be determined and taken into account for future samples of a 
similar nature. Another commonly used method to account for matrix effects is the use of 
internal standards (Benijts et al. 2004). These can be isotopically labeled versions of the 
compound of interest or compounds that behave very similarly to the compound of interest and 
are not found in the sample itself. Known concentrations of internal standards are added to the 
collected samples prior to extraction, allowing these compounds to interact with the matrix and 
undergo the same processes as the sample. Therefore, quantification of the internal standard can 
account for any loss during sample analysis or suppression/enhancement due to the matrix, 
allowing for an appropriate adjustment for compounds originally found in the sample.  
In addition to the limitations of the chemical analysis, there are also constraints to using 
the YES. This assay uses receptors to measures the total estrogenicity of the sample, however 
this can be influenced by the complexity of the sample matrix since a response will be induced 
by any chemical that binds and activates the receptor. Therefore, the specific chemicals causing a 
total estrogenic response in the YES assay is uncertain. In addition, other compounds (anti-
estrogens) in effluents/extracts may block the receptor and prevent the estrogen response from 
occurring, resulting in the underestimation of the total estrogenicity of the sample (Jung et al. 
2004). Consequently, each of the methods have specific biases that must be considered, and a 
weight of evidence approach is advisable.   
1.5 Study Objectives 
 This study aimed to develop a reliable analytical method for the detection of estrogens in 
wastewater effluents and apply this method to quantify concentrations in selected plants to 
support other related studies modelling concentrations and effects in receiving waters.  Samples 
for the study were from two sources. The first group of samples were composite influent and 
effluent samples collected from nine wastewater treatment plants across southern Ontario with 
varying degrees of treatment (including Kitchener and Waterloo) and were provided through a 
collaboration with Environment and Climate Change Canada.  The second group of samples 
were grab samples from Waterloo and Kitchener and were collected during a period of major 
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treatment plant upgrades between 2010 and 2018.  Archived extracts were available from 
previous studies and new samples were collected for the current study between 2017 and 2018.  
The objectives were to: 1) Apply a robust methodology for estrogen analysis to influent 
and effluent samples from Canadian WWTPs; 2) contrast the concentrations of estrogens in 
influent and final effluent (i.e. removal); 3) determine the temporal pattern of estrogens in 
Waterloo and Kitchener over a period of treatment plant upgrades and 4) use various analytical 
techniques to explore and understand the fluctuations in estrogens.  For each sample set analysis 
was completed for estrogens using LC-MS/MS (QQQ) and total estrogenicity using the YES 









Chapter 2 – Analysis of PPCPs and EDCs in influent and effluent 
across nine Canadian WWTPs  
 
WWTPs and their discharge has been a major area of study for several years as they have 
direct impacts on the surrounding environment. As new contaminants emerge the focus of study 
changes with time and currently some of the emerging contaminants of concern are 
pharmaceuticals and hormones. At very low concentrations, hormones such as 17α-
ethinylestradiol (EE2) have been reported to have effects on aquatic species. Kidd et al. (2007) 
showed that concentrations as low as 5 ng/L can cause a collapse in fish community, while 
Parrott et al. (2005) showed that 1 ng/L impacted the reproductive success of fathead minnows.  
Several studies have also been done on the impacts of hormones in the Grand River. 
EDCs and PPCPs found in effluent have been linked to impacts on fish health, including intersex 
(Hicks et al. 2017), and the in vitro production of steroid hormones in fish (Marjan et al. 2018). 
Although these compounds can have impacts on the environment and aquatic life downstream of 
discharge sites, they are not monitored or regulated in Canadian wastewater systems. Studies 
have been performed on the treatment and removal of PPCPs and EDCs, linking increased 
removal to nitrification and solid retention times, however they are only partially removed 
(Achermann et al. 2018; Servos et al. 2005; Ternes et al. 1999).  
In Europe, an environmental quality standards (EQS) list, which includes several 
chemicals such as estrogenic hormones, was recently introduced for monitoring and regulatory 
decision making purposes (Carvalho et al. 2015). The European commission has set the 
acceptable annual average of EE2 as 0.035 ng/L (European Commission 2011). However very 
few methods can detect concentrations that low, especially considering the low initial 
concentrations and the influence of matrix interferences. Therefore, there is very little compiled 
data available for Canadian WWTPs. The objective of this study was to determine the presence 
of estrogens in effluents in several treatment plants using different processes and having different 
effluent quality. Influent and effluent samples from nine WWTPs across southern Ontario were 





Reference compounds were purchased from Sigma Aldrich and CND Isotopes. Standard 
solutions were stored at -20℃. All solvents used were HPLC grade.   Stock solutions of all the 
analytes were prepared at a concentration of 1 g/L in methanol which was used to prepare a 
calibration curve with the concentrations of 0, 0.5, 1, 10, 50, 100, 200, 500, 1000, 3000, 5000 
µg/L. The YES assay was performed using the Yeast β-Galactosidase Assay Kit from Thermo 
Scientific.  
2.1.2 Sample Collection  
Composite and grab samples were collected just before the outfall from 9 wastewater 
treatment plants (WWTPs) in southern Ontario between May 2017 to August 2018 (Table 2.1). 
Influent and effluent were collected by Environment Canada and Climate Change in cooled 
(4℃) 24-h composite samplers on three sequential days. Three 1 L glass amber bottles were 
collected from the composite samples per day and preserved with 50 mg/L ascorbic acid and 1 
g/L sodium azide on site. The samples were then transported to the University of Waterloo and 
filtered through a 47 mm glass fiber filter (Pall Corporation, Mississauga, ON) and stored at 4C. 
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1. Day 3 influent results were strange, sent for re-analysis, therefore not included in the average. 
2. In these cases, nitrification means the Certificate of Approval for the WWTP includes requirement to nitrify  
All samples were collected during dry weather and all plants were operating normally 







2.1.3 Sample Extraction  
Prior to extractions, the filtered 1 L effluent samples were split into the appropriate 
volumes for the extractions of hormones, total estrogenicity, and pharmaceuticals using solid 
phase extractions (SPE). The analytes of interest in this study are listed in Table A2.1. 
Extractions were done manually or using the ThermoFisher AutoTrace™ (Dionex, Sunnyvale, 
CA). With each batch of samples extracted, quality assurance/quality control (QA/QC) samples 
were also processed. Each batch was extracted with two matrix spikes (MS1, MS2) as positive 
controls and a blank as a negative control. These samples were prepared using 100 mL of MilliQ 
water and spiked with 100 µL of 100 µg/L regular and deuterated standards for matrix spikes, or 
100 µg/L deuterated standards for the blanks.   
2.1.3.1 Hormones 
The hormone extraction was performed using Superclean LC-18 cartridges (6 cc, 500 mg, 
Sigma Aldrich) preconditioned with methanol and MilliQ water. A 100 mL sample, spiked with 
100 µL deuterated internal standard, was loaded onto the cartridge. The cartridge was then 
allowed to dry before eluting the analytes with ethyl acetate. The samples were evaporated to 
dryness under nitrogen before being reconstituted in 500 µL of methanol with 75 µg/L 
lorazepam and chloramphenicol, two compounds which are not found in the samples and 
therefore used as QA/QC. Samples were stored at -20°C. 
2.1.3.2 Total Estrogenicity  
Extractions for total estrogenicity were performed using Oasis HLB cartridges (6cc, 
500mg, Waters) preconditioned with methyl tert-butyl ether (MTBE), methanol, and MilliQ 
water. A 500 mL or 1 L of unspiked sample was loaded onto the cartridge. The cartridges were 
then rinsed with MilliQ water before eluting the analytes with methanol and 10% methanol in 
MTBE. The samples were evaporated to dryness under nitrogen before being reconstituted in 
500 µL of methanol then stored at -20°C. 
2.1.3.3 Pharmaceuticals and Personal Care Products  
The pharmaceutical extraction was performed using Bond Elut Plexa cartridges (6 cc, 
500 mg, Agilent) preconditioned with methanol and MilliQ water. A 100 mL sample was 
brought to pH 2 ± 0.05 and then spiked with 100 µL deuterated internal standard before loading 
onto the cartridge. The cartridges were then rinsed with MilliQ water and 5% methanol in water 
before eluting the analytes with methanol. The samples were evaporated to dryness under 
nitrogen before being reconstituted in 500 µL of methanol with 75 µg/L lorazepam and 
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chloramphenicol. Lorazepam and chloramphenicol were used as instrument controls to ensure 
proper injection of the samples. Samples were stored at -20°C. 




Cartridge Conditioning Elution 
Final 
Volume  
Hormones 100 mL 
Superclean LC-
18 cartridges (6 
cc, 500 mg, 
Sigma Aldrich) 
5 mL Methanol 
5 mL MilliQ 
Water 
5 mL Ethylacetate 








5 mL methyl 
tert-butyl ether 
(MTBE) 
5 ml Methanol 
5 mL MilliQ 
Water 
5 mL Methanol 
5 mL 90% MTBE 
in methanol 
0.5 mL 
PPCPs 100 mL 
Bond Elut 
Plexa cartridges 
(6 cc, 500 mg, 
Agilent) 
5 mL Methanol 
5 mL MilliQ 
Water 
3 mL Methanol 
3 mL Methanol 
0.5 mL 
 
2.1.4 Sample Analysis 
Following the extraction of final effluent samples, the reconstituted extracts were 
analyzed for hormones, pharmaceuticals and total estrogenicity using different analytical 
techniques optimized for the analytes of interest. Detection limits for the chemical analyses were 
determined by McCann (2016) and are reported in Appendix A5. Instrument detection limits 
(IDL) and quantification limits (IQL) were determined by repeated injections of blanks (n=7) 
and the calibration curve. The IDLs and IQLs were calculated as three times and ten times the 
standard deviation of the blanks respectively. Method detection limits (MDLs) were determined 
by measuring multiple wastewater samples spiked at various concentrations (n=7). Values were 
calculated using a student’s t-test value at 99% confidence multiplied by the standard deviation.  
The YES assay kit used had a linear absorbance range of 0.02-1.00 and samples are analyzed 








 2.1.4.1 Nutrients  
Nutrient analysis was provided by Environment and Climate Change Canada using the 
methods listed in Table 2.3.  
 




Alkalinity, Total (CaCO3) Titrimetry 0.3 
Ammonia as N Colorimetry – Phenate 0.250 
Nitrate as N Chem Suppress IC 0.02 
Nitrate/Nitrite as N Chem Suppress IC 0.03 
Nitrite as N Chem Suppress IC 0.006 
BOD B_BOD_Water 2.0 
COD Spectrophotometry 4.8 
pH Potentiometry - 
Nitrogen, Total Kjeldahl Colorimetry -Black Digest Phenate 0.700 
Solids, Total Suspended (TSS) Gravimetry 5.0 
Solids, Volatile Suspended (VSS) Gravimetry 6.0 
 
The un-ionized ammonia concentration in the final effluent was calculated from the 
measured ammonia concentration, pH and temperature of the sample. Equation 1 was used to 
calculate the dissociation constant (pKa), where T is temperature in Kelvin. The pKa was used to 
determine the fraction of total un-ionized ammonia (Equation 2). These equations were based on 
the Canadian Water Quality Guidelines for the Protection of Aquatic Life (CCME 2010).   
Equation 1. pKa calculation 










2.1.4.2 Hormones - LC-MS/MS QQQ  
 Analysis of hormones was performed using an Agilent 1260 HPLC, equipped with a HiP 
Sampler, binary pump, and an Agilent 6460 triple quadrupole (QQQ) mass spectrometer with an 
Agilent Jet Stream (AJS) electrospray ionization. 10 µL of reconstituted hormone extract was 
injected onto an Agilent ZORBAX Eclipse Plus C18 (2.1 mm x 50 mm x 1.8 μm) HPLC column, 
held at 35℃, to chromatographically separate the analytes of interest, achieved with a flow rate 




Table 2. 4 Hormone LC-MS/MS QQQ mobile phase parameters  
Mobile Phase A: 5 mM Ammonium fluoride in MilliQ 
Mobile Phase B: 100% Acetonitrile 
Time (min) % Mobile Phase A % Mobile Phase B 
0 90 10 
10 0 100 
13 0 100 
13.10 90 10 
 
Following separation, analytes were identified and quantified using a dynamic multiple 
reaction method optimized on the triple quadruple. The method was run in a negative ionization 
mode with a source temperature of 700℃, gas temperature of 250℃, gas flow 10 L/min, 
nebulizer at 30 psi, and a capillary voltage of 4000V. The compound parameters were optimized 
to the values indicated in Table 2.4. With each batch of samples analyzed on the triple 
quadrupole a calibration curve ranging from 0.5 ng/L to 5000 ng/L was also injected.  
Table 2. 5 Optimized compound parameters  
Compound Precursor Ion Product Ion Frag (V) CE (V) Cell Acc (V) Ret Time (min) 
4 NP – d4 223.27 110.1 79 18 4 12.09 
4 NP Linear 219.34 106.1 98 18 4 12.13 
4 NP Mixture 219.34 147.1 130 26 4 11.46 
4 NP Mixture 219.34 133.1 130 30 4 11.46 
4 OP 205.3 106.1 90 14 4 11.53 
4 OP – d17 222.4 108.1 90 18 4 11.46 
BPA 227.3 212.3 128 14 4 7.86 
BPA 227.3 133.2 128 26 4 7.86 
BPA – d16 241.28 223.3 140 16 4 7.82 
BPA – d16 241.28 142.2 140 24 4 7.82 
E1 269.4 145.1 155 38 4 8.3 
E1 269.4 143.1 155 45 4 8.3 
E1 – d2  271.2 147.1 170 38 4 8.3 
E1 – d2  271.2 145.1 170 58 4 8.3 
E1 – d4  273.4 147.1 187 36 4 8.3 
E1 – d4 273.4 145.1 187 50 4 8.3 
E2 271.4 145.1 200 40 4 7.99 
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Compound Precursor Ion Product Ion Frag (V) CE (V) Cell Acc (V) Ret Time (min) 
E2 271.4 143.1 200 56 4 7.99 
E2 – d4 275.2 187.2 147 42 4 7.95 
E2 – d4 275.2 145.3 147 34 4 7.95 
E3 287.4 171.2 170 30 4 6.23 
E3 287.4 145.1 170 38 4 6.23 
E3 – d2 289.39 173.2 200 33 4 6.23 
E3 – d2 289.39 147.1 200 37 4 6.23 
E3 – d2 289.39 145.1 200 53 4 6.23 
EE2 295.39 144.9 170 38 4 8.37 
EE2 – d4 299.4 161.2 170 34 4 8.37 
EE2 – d4 299.4 147.2 170 38 4 8.37 
TCS 286.99 35 90 10 4 10.5 
TCS – d3 289.99 35 90 9 4 10.46 
 
2.1.4.3 Pharmaceuticals and Personal Care Products - LC-MS/MS QTRAP 
 PPCPs were analyzed using an Agilent 1200 HPLC (Agilent, San Pedro, CA) connected 
to a Sciex 3200 Triple Quadrupole Linear Ion Trap (QTRAP) mass spectrometer (ABSciex, 
Concord, ON, Canada) with electrospray ionization (ESI). Compound separation was achieved 
by injecting 20 µL of reconstituted PPCPs extract onto an Agilent Eclipse XDB-C18 (4.6 mm x 
150 mm x 5 μm) column using the mobile phase gradient described in Table 2.4 at a flow rate of 
800 µL/min. 
Table 2. 4 PPCPs LC-MS/MS QTRAP Mobile Phase Parameters 
Mobile Phase A: 5 mM Ammonium acetate in MilliQ  
Mobile Phase B: 100% Methanol 
Negative Ionization Mode Positive Ionization Mode 
Time 
(min) 










0.00 90.0 10.0 0.00 90.0 10.0 
0.50 90.0 10.0 0.50 90.0 10.0 
0.51 60.0 40.0 0.51 50.0 50.0 
8.00 0.0 100.0 8.00 0.0 100.0 
11.00 0.0 100.0 10.00 0.0 100.0 
11.50 90.0 10.0 10.01 90.0 10.0 




 Following separation, the compounds were identified and quantitated on the 
QTRAP using a multiple reaction method (MRM) with optimized instrument parameters for the 
analytes of interest identified by McCann (2016) (Table 2.5, Table 2.6). With each batch of 
samples analyzed on the QTRAP a calibration curve ranging from 0.5 ng/L to 5000 ng/L was 
also injected.  
Table 2. 5 LC-MS/MS QTRAP Optimized Source Parameters (McCann 2016) 
 Positive Ionization Negative Ionization 
CUR 30 10 
CAD Med Med 
IS Voltage 5500 -4500 
Temp 750 750 
GS1 50 60 
GS2 30 40 
 
Table 2. 6 Optimized PPCP Parameters (McCann 2016) 
ID Q1 Q3 
Time 
(ms) 
DP EP CEP CE CXP 
RT 
(mins) 
Positive Ionization Mode 
ACE 152.096 109.9 100 51 7.5 10 21 3 4.009 
ACE-d4 156.106 113.9 100 51 10 10 23 4 4.009 
ATEN 267.2 145.1 100 51 3 30 36 5 3.779 
ATEN-d7 274.3 145.2 100 49.81 3.7 41.4 35.6 3.7 3.779 
ATOR 559.3 440.2 100 83 5.9 18.91 32 22 6.988 
ATOR-d5 564.3 445.3 100 45.6 4 25.943 30 16 6.988 
ATRZ 216.2 174.3 100 66.9 3.8 13.5 27 2.4 7.233 
ATRZ-d5 221.1 179.3 100 67.9 4.1 16.334 22.1 3 7.233 
CAFF 195.2 123 100 47 3.4 8.8 41 5 4.415 
CAFF-d3 198.2 123.1 100 42 3 15 42 4 4.415 
CBZ 237.1 193.3 100 55 4.9 14.3 51 2.7 6.565 
CBZ-d10 247.2 204.4 100 60.9 4.3 17.065 28 3.31 6.565 
Desven 264.2 58.2 100 21 2 16 39 8 4.704 
Desven-d6 270.2 64 100 21 7 40 39 8 4.704 
e-CBZ 253.2 180.3 100 26 5.5 17.233 33 4 5.454 
e-CBZ-d10 263.2 190.3 100 53 3.5 20 34 5 5.454 
FLX 310.3 44.3 100 48 2.9 12.08 44 7 7.38 
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ID Q1 Q3 
Time 
(ms) 
DP EP CEP CE CXP 
RT 
(mins) 
FLX-d5 315.2 44.2 100 50 4 18.969 38.2 3.1 7.38 
LIN 407.3 126 100 60 9 21.547 49.7 4 6.398 
LIN-d3 410.28 129.2 100 36 8.5 18 43 4 6.398 
Lorazapam1 321.1 275.1 100 60.1 5.1 19.134 32.8 3 7.02 
MET 130.132 71.1 100 36 3.5 10 29 4 2.249 
MET-d6 136.145 77 100 36 4 10 29 4 2.249 
MON 693.4 675.4 100 124.7 9.6 29.558 55.9 10.9 10.234 
NFLX 296.1 134.1 100 23 3 9.5 9 5 7.213 
NFLX-d5 301.2 139.2 100 23 3 10 9 5 7.213 
o-ATOR 575.229 440.3 100 46 7.5 20 25 14 6.679 
o-ATOR-d5 580.2 445.2 100 64 4 19 32 5 6.679 
Oxybenzone 229.053 151 100 56 5.5 14 27 4 8.807 
Oxybenzone-d5 234.1 151.1 100 51 8 14 27 4 8.807 
p-ATOR 575.23 440.301 100 46 7.5 20 25 14 5.839 
p-ATOR-d5 580.201 445.201 100 64 4 19 32 5 5.839 
SMZ 279.084 92 100 36 4.5 14 41 5 4.27 
SMZ-d4 283.14 96 100 41 4 14 43 8 4.27 
SULFA 254.1 156.2 100 41 3 9 22.1 3 4.222 
SULFA-d4 258.122 160.1 100 36 12 14 21 4 4.222 
TRIM 291.1 261.2 100 59 4 12 32 3 4.537 
TRIM-d3 294.2 230.3 100 46 8.5 22 31 6 4.537 
VEN 278.3 58.1 100 38.2 2.9 21 42 8 6.161 
VEN-d6 284.271 64.1 100 26 11 8 35 8 6.161 
Negative Ionization Mode 
BPA 227 211.9 200 -53 -10 -20.055 -28 -5 8.092 
BPA-d16 241 142 200 -50 -10 -20.573 -50 -3 8.092 
BPA2 227.036 212.1 200 -60 -2 -10 -26 -2 8.092 
Chloramphenicol 321 151.9 200 -53 -1 -23.533 -23.1 -1   
DCF 293.9 250 200 -46 -2.5 -22.53 -15 -1.7 7.814 
DCF-d5 298.2 253.8 200 -25.8 -6.9 -22.689 -16.9 -6.1 7.814 
EE2 295.1 144.9 200 -71.8 -7 -10 -54 -3 8.669 
EE2-d4 299.1 146.9 200 -72.9 -5 -28.23 -51.8 -15.1 8.669 
GFZ 249.1 121.1 200 -55 -2 -20.873 -17 -3 9.488 
GFZ-d6 255 120.7 200 -46.5 -11 -21.091 -19.24 -2 9.488 
IBU 204.9 160.9 200 -41 -2.6 -19.237 -11 -0.5 8.209 
IBU-d3 207.9 164.1 200 -25.1 -7.6 -19.348 -10 -3 8.209 
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ID Q1 Q3 
Time 
(ms) 
DP EP CEP CE CXP 
RT 
(mins) 
NPX 229 170 200 -29 -1.9 -20.129 -25 -3.8 6.69 
NPX-d3 232.1 172.8 200 -15 -5 -10 -20 -3 6.69 
NPX-d4 233 169.9 200 -36.8 -2 -20.277 -25.7 -1 6.69 
TCCB 314.8 161.6 200 -50 -3 -12 -20 -13 10.319 
TCCB-d2 316.9 159.9 200 -50 -2.5 -23.381 -18 -2 10.319 
TCS 286.9 35 200 -33 -2 -7 -30 -3 10.284 
TCS-d3 289.9 35 200 -28.5 -2 -11.31 -25.3 -2.3 10.284 
1. Lorazepam was used as an internal standard for monensin  
2.1.4.4 Total Estrogenicity - YES Assay  
 Total estrogenicity of the samples was measured using the Yeast Estrogen Screen (YES) 
assay as outlined by Arlos et al. (2018.)  Buffers and media required for this analysis were 
prepared as outlined in Appendix A2 (Table A2.1, Table A2.2). Saccharomyces cerevisiae cells 
(Receptor: ERtrp (YePtrpER), Reporter E2.ura (YRpE2ura)), stored in 30% glycerol stock at -
80oC, were provided by Heidi Engelhardt, University of Waterloo (originally from K. Gaido, 
Research Triangle Park).  
 A stock of S. cerevisiae was thawed at 4oC and streaked onto an agar plate. Plates were 
incubated at 30oC, shaking at 300 rpm for 3 d or until individual colonies were visible on the 
plate. The plates were then stored at 4oC for up to 14 d. A single colony from the streak plate was 
used to inoculate 1mL of selective GOLD media and incubated at 30oC, 300 rpm for 24 h to 
allow cell growth. The cells were then diluted 1:10 with minimal media and incubated at the 
same conditions for another 24 h. A further 1:1 dilution of the cells was made using minimal 
media and incubated for 4-6 h at the same conditions. After 4-6 h, cells were diluted with a 
solution of copper II sulfate and minimal media until an optical density (OD) of 0.03 was 
obtained at 660 nm.  
 To expose the cells, 10 µL of standard (68.10 µg/L – 0.03 µg/L E2) or sample (serially 
diluted 1:1 up to 1024x dilution) was transferred to a 2 mL amber glass vial in duplicate and left 
in the laminar flow hood to allow the methanol to evaporate. Along with the calibration curve 
and samples, QA/QC samples were also run in duplicate. The blank consisted of an empty vial, 
positive control had 10 µL of standard level 8 (2.13 µg/L E2), and the negative control had 10 
µL of methanol. Once the methanol had evaporated, 200 µL of the diluted cells (OD 0.03) was 
added to each vial. Cells were exposed for 18-24 h at 30oC, shaking at 300 rpm.  
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 To measure the estrogenicity, a yeast β-Galactosidase assay kit (Thermo Scientific) was 
used. The 2x yeastβ-Galactosidase assay buffer, stored at -20oC was thawed at 4oC. After the 
cells had been exposed for 18-24 h, 25 µL aliquots from each vial was transferred into a well on 
a 96-well plate and diluted with 75 µL of minimal media. The cell density of each well was 
measured at 660 nm before adding 100 µL of a 1:1 solution of 2x yeastβ-Galactosidase assay 
buffer and yeast protein extraction reagent (Y-PER). The reaction was measured at 420 nm every 
25 secs, for 30 mins on a Molecular Devices Max 3 spectrophotometer plate reader (Sunnydale, 
CA, USA). Samples below the detection limit of the assay were further concentrated to 80 µL 
and analyzed again using the YES assay.  
2.1.4.5 Data Analyses  
 Analyte peaks produced by the QQQ and QTOF were integrated using Agilent 
MassHunter Quantitative Analysis software version B.06.00, peak data from the QTRAP were 
integrated using the Analyst software version 1.6.2. Analyte concentrations were determined by 
comparing the ratio between the peak area of the analyte and the peak area of the deuterated 
internal standard peak area to the ratios of the calibration curve injected with the batch of 
samples. Dilution factors were accounted for to determine the concentration in the initial sample 
volume. The apparent percent reduction (difference) between corresponding influent and effluent 
samples was calculated using Equation 3. The calculated total estrogenicity of the sample was 
determined using Equation 4 by taking the EEQ of each estrogen and their concentration into 
account.  
Equation 3. Percent Reduction  
 𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑅𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 =




Equation 4. Calculated Total Estrogenicity (ng/L E2 equivalents) 
𝑇𝑜𝑡𝑎𝑙 𝐸𝑠𝑡𝑟𝑜𝑔𝑒𝑛𝑖𝑐𝑖𝑡𝑦
=  ([𝐸2] × 𝐸𝐸𝑄𝐸2) + ([𝐸1] × 𝐸𝐸𝑄𝐸1) + ([𝐸3] × 𝐸𝐸𝑄𝐸3) + ([𝐸𝐸2] × 𝐸𝐸𝑄𝐸𝐸2) 
 
From the YES Assay, absorbance values measured per well over the course of 30 mins 
were used to determine the rate of B-galactosidase activity. The absorbance measured per well 
was corrected for the number of cells in the well using the OD660 measurement and the β-
galactosidase activity was calculated using Equation 5, where t represents time (min) of 
incubation and v is the volume (mL) of cells used in the assay. The assay kit used for this 
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analysis is linear between an OD420 of 0.02 and 1.0, therefore time points with absorbances 
outside of this range were not included in the analysis. Wells with cell death were also not 
included in the analysis.  
Equation 5. B-galactosidase Activity 
𝑨𝒄𝒕𝒊𝒗𝒊𝒕𝒚 =  
𝟏𝟎𝟎𝟎 × 𝑨𝟒𝟐𝟎
𝒕 × 𝒗 × 𝑶𝑫𝟔𝟔𝟎
 
 
 The β-galactosidase activity of the calibration curve and the samples were normalized to 
the maximum and minimum response of the calibration curve and fit to a regression model 
(Sigmoidal, Hill, 4 Parameter) using Sigma Plot (Equation 6). Using this model, the normalized 
β-galactosidase activity of the samples was calculated and subsequently the total estrogenicity of 
each well was expressed as an E2 equivalence in ng/L using Equation 7.  
Equation 6. Four Parameter Logistic  











Statistical analysis was performed on all data using SigmaPlot version 13.0. A two-way 
ANOVA along with a pairwise multiple comparison (Tukey test) was used to identify statistical 
differences due to site or sample type in total estrogenicity, estrogen concentrations, and 
pharmaceutical concentrations (P<0.05). A two-way ANOVA was also used to identify statistical 
differences in the percent difference of the estrogens and pharmaceuticals between influent and 
effluent samples from the various sites (P<0.05).  Additionally, a paired t-test was used to find 
statistical differences in the calculated and measured total estrogenicity.  
 
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 =  
𝐶𝑜𝑛𝑐.  𝑜𝑓 𝐸2 (
𝑚𝑜𝑙
𝐿
) × 𝑉𝑜𝑙 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑤𝑒𝑙𝑙 (𝜇𝐿)
𝑉𝑜𝑙 𝑜𝑓 𝑒𝑥𝑡𝑟𝑎𝑐𝑡 𝑡ℎ𝑒 𝑐𝑒𝑙𝑙𝑠 𝑎𝑟𝑒 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑡𝑜 (𝜇𝑙)





𝑓𝑖𝑛𝑎𝑙 𝑟𝑒𝑐𝑜𝑛𝑠𝑡𝑖𝑡𝑢𝑡𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒 𝑎𝑓𝑡𝑒𝑟 𝑑𝑟𝑦𝑖𝑛𝑔(𝑚𝐿) 




2.2 Results  
2.2.1 Effluent quality 
The treatment plants sampled represented a wide variety of plants with differing 
treatment processes (Table 2.1) and therefore had different effluent quality (Table 2.5).  The 
percent reduction of select parameters are described in Table 2.6. The total Suspended Solids 
(TSS) had over 97% reduction with over 200 mg/L in influent and effluent samples ranging from 
<5.0 to 12.2 mg/L. pH and temperature of the samples collected remained consistent. pH ranged 
from 7-9 for all influent and effluent samples, with the temperature of effluent samples being 
between 16-21°C. Biological oxygen demand (BOD) and chemical oxygen demand (COD) are 
both traditionally targeted nutrient parameters and both were reduced by over 90% and 80% 
respectively. Final effluent concentrations of BOD were below 9 mg/L while COD 
concentrations were between 30-110 mg/L. Ammonia had over 99% removal, except at Plants A 
(89%), B (95%), E (93%), F (53%), and I-a (90%). Similar patterns were seen in the removal of 
total Kjeldahl nitrogen (TKN), with over 95% removal except at Plants A, B, E, F, and I-a. With 
lower removal of ammonia, it was expected that these plants would have lower concentrations of 
nitrate produced, however it was not always the case. Despite the high concentration of ammonia 
at Plants A and B, these plants had high levels of nitrate in the effluent, 25 and 29 mg/L 
respectively. In addition, Plant C which had 99% removal of ammonia had only 0.1 mg/L of 
nitrate detected in the final effluent, whereas Plant F with 53% removal of ammonia had 9.7 
mg/L of nitrate.  
The unionized form of ammonia is very toxic and therefore important. However, the 
percentage of total ammonia that exists as unionized ammonia is a function of both temperature 
and pH. The CCME environmental quality guideline for unionized ammonia is 0.019 mg/L 
(CCME 2010) while the Wastewater Effluent Systems Regulation targets 1.25 mg/L, expressed 
as nitrogen (N), at 15°C ± 1°C.  But it also states that the effluent must not be acutely lethal to 
fish. Plants A, B, I-a slightly exceed the proposed limits and guidelines for ammonia while plant 




Table 2. 6 Nutrient parameters of influent and effluent collected from various Ontario WWTPs 




























A Inf 30.8 2.3 <0.02 0.0 46.6 5.1 366.7 72.7 176.0 19.4 492.3 134.2 7.6 0.0 -  
 Eff 3.2 1.7 29.3 1.5 6.0 2.3 6.6 0.2 8.3 1.3 63.7 7.8 7.6 0.1 19.0 0.05 
B Inf 29.1 1.5 <0.02 0.0 50.5 0.1 294.0 39.5 262.0 21.2 614.3 94.0 7.6 0.0 -  
 Eff 1.5 0.7 24.9 3.4 4.0 0.9 <5.0   5.9 0.5 48.3 3.8 7.7 0.1 21.0 0.03 
C Inf 53.0 4.7 <0.02 0.0 86.4 2.5 358.7 44.5 221.0 5.6 614.7 50.5 8.3 0.0 -  
 Eff 0.3 0.1 0.1 0.0 2.8 0.1 5.7   8.6 3.1 109.7 7.5 7.9 0.1 20.0 0.01 
D Inf 25.1 2.4 0.5 0.2 38.9 3.8 716.0 278.7 192.7 13.3 504.3 83.8 7.6 0.1 -  
 Eff 0.1 0.0 19.5 1.2 1.1 0.1 <5.0   4.7 0.1 37.0 3.0 8.1 0.0 18.0 0.01 
E Inf 16.8 1.6 <0.02 0.0 29.1 3.8 298.3 93.6 278.0 71.4 542.0 144.0 7.0 0.1 -  
 Eff 1.2 0.6 14.5 2.9 2.9 1.0 <5.0   5.9 0.1 42.3 1.5 7.7 0.1 17.0 0.02 
F Inf 21.7 1.4 <0.02 0.0 37.3 1.2 312.0 45.7 206.7 12.2 545.3 84.3 7.1 0.1 -  
 Eff 10.1 1.2 9.7 1.1 16.9 0.5 <5.0   5.6 0.1 30.0 0.6 7.5 0.0 17.0 0.11 
G Inf 22.3 1.0 0.1 - 33.5 0.8 210.0 9.9 182.7 1.8 467.0 9.7 7.5 0.0 -  
 Eff 0.0 0.0 24.7 0.7 2.2 0.3 <5.0   3.9 0.2 46.3 0.3 7.9 0.1 21.0 0.00 
H Inf 35.6 2.9 <0.02 0.0 50.5 4.6 314.0 15.7 266.0 7.2 580.7 18.9 7.5 0.0 -  
 Eff 0.2 0.1 31.4 2.4 2.9 0.3 <5.0   4.7 0.8 47.3 5.0 7.9 0.0 20.0 0.00 
I-a Inf 24.4 2.1 <0.02 0.0 42.4 3.2 290.0 73.5 250.0 4.0 533.7 74.0 7.4 0.0 -  
 Eff 2.4 0.6 3.2 0.3 4.1 0.6 10.0   6.0 0.4 52.3 2.7 7.8 0.0 16.0 0.05 
I-b Inf 23.7 3.2 <0.02 0.0 43.2 1.1 379.0 39.3 304.0 17.1 638.7 50.3 7.4 0.0 -  
 Eff 0.1 0.0 25.0 0.7 1.2 0.2 12.2 5.6 5.4 0.5 36.0 2.5 7.9 0.0 21.0 0.00 
1. Nutrient Parameters: Ammonia as N (NH3), Nitrate as N (NO3-), Nitrogen, Total Kjeldahl (TKN), Total suspended solids 
(TSS), Biological Oxygen Demand (BOD), Chemical Oxygen Demand (COD), pH, Temperature  
2. Day 3 influent sample had very high results. Re-checking with lab, not included in average 
3. Un-ionized ammonia calculated from effluent ammonia concentrations, taking pH and temperature into consideration  
















A 95 89 98 88 89 
B 97 93 99 91 95 
C 97 82 99 97 99 
D 97 92 99 97 99 
E 98 92 99 93 93 
F 97 94 99 54 53 
G 98 90 99 94 100 
H 98 92 99 951 100 
I-a 98 89 99 89 90 
I-b 98 94 97 97 100 
1. Day 3 influent sample had very high results. Re-checking with lab, not included in 
average 
2.2.2 Pharmaceuticals  
Both influent and effluent samples were analyzed for the 24 pharmaceuticals listed in Appendix 
A1 (Table A1.1) using the LC-MS/MS QTRAP. The percent difference in concentration of each 
pharmaceutical after treatment was calculated and can be found in Table 2.8. Lincomycin (LIN) 
and monensin (MON) could not be detected in either influent or effluent. Atrazine (ATRZ) was 
only detected in influent from plants G, however concentrations ranging from 4-30 ng/L was 
found in effluent from all plants sampled. As a result, a difference could not be accurately 
determined. Among the different pharmaceuticals measured, caffeine (CAFF), ibuprofen (IBU), 
and naproxen (NPX) had consistently higher percent differences between influent and effluent at 
all plants whereas compounds such as carbamazepine (CBZ), venlafaxine (VEN), 
sulfamethoxazole (SULFA), and fluoxetine (FLX) and consistently low differences (<80%). 
However, unlike the other plants sampled, Plant C had increased differences of all compounds, 
including compounds that were not easily removed by other plants. This plant had over 80% 
difference in concentration of all compounds analyzed except for carbamazepine (CBZ), 







Table 2. 8 Percent difference of pharmaceuticals  
 Percent Difference (%) 
 A B C D E F G H I-a I-b 
ATRZ ND ND ND ND ND ND 27 ND ND ND 
CBZ -43 -40 67 -1 -8 -72 -9 0 -77 -80 
FLX 8 55 100 54 40 13 2 31 52 80 
ATOR -16 38 100 96 89 20 100 73 92 100 
VEN 4 5 98 16 19 16 38 3 -5 -1 
LIN1 - - - - - - - - - - 
MON1 - - - - - - - - - - 
SULFA 18 13 99 39 49 -35 91 16 42 48 
TRIM -16 24 100 100 17 10 94 7 49 97 
NFLX 22 88 100 100 87 51 100 83 100 100 
CAFF 100 100 100 100 100 64 100 100 100 100 
e-CBZ -29 -5 86 -2 27 18 17 -24 29 -3 
p-ATOR -10 33 100 99 88 14 100 78 95 100 
o-ATOR 4 37 100 99 87 10 100 76 89 100 
SMZ 79 74 90 96 51 -168 100 78 24 100 
ACE 100 100 100 100 100 100 NQ NQ 100 NQ 
DES -44 32 99 -31 60 55 95 -45 -22 -47 
IBU 94 100 100 96 100 90 99 99 98 100 
BPA 96 100 89 67 100 43 90 88 60 90 
NPX 99 99 100 99 98 98 100 99 99 100 
GFZ 72 97 ND 98 97 39 95 96 59 ND 
DCF -33 28 97 38 3 -3 82 35 -10 61 
TCS 60 91 99 97 76 58 74 90 236 95 
TCCB 40 86 84 100 52 63 NQ NQ 78 NQ 
1.No LIN or MON detected in either influent or effluent  
ND – Not detected in influent samples but quantifiable in effluent  
NQ – Not quantified  
The concentrations of CBZ in influent and effluent were only significantly different at 
plants C, F, I-a, and I-b (p= <0.001, 0.013, 0.008, 0.007) (Fig. 2.1). Plant C had a significant 
decrease in concentrations whereas plants F and I both had significantly higher concentrations in 
the final effluent compared to influent samples. It can also be seen that concentrations of VEN in 
influent and effluent were only significantly different at plants C and G, with decreased 
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concentrations in the effluent samples (p= <0.001, 0.002). The concentration of IBU in influent 
and effluent were significantly different at all plants sampled (p<0.001). Concentrations of NPX 
in influent and effluent were statistically different at all plants (p<0.001). 
 
Figure 2.1 Mean concentration of select pharmaceuticals in influent and effluent. 
Carbamazepine, venlafaxine, ibuprofen, and naproxen concentrations were measured in influent 
(striped) and effluent (solid) samples from various WWTPs. The log concentration along with 
standard error was plotted to show the difference between the samples from each site. Significant 
differences (p<0.05) between influent and effluent concentrations of the pharmaceuticals 
measured from the different WWTPs are indicated by *.  
2.2.3 Hormones  
Influent and effluent samples from the various WWTPs were analyzed on the LC-MS/MS 
QQQ to determine the concentrations of the estrogens E1, E2, EE2, and E3 (Appendix A.4). It 
was found that the concentration of E2 detected in influent (9-28 ng/L) was significantly 
different from effluent concentrations (1-6 ng/L) at each plant (p < 0.001). The percent 
difference of the samples ranged from 62 to 92% across the different plants (Table 2.9).  
Significant differences were also found in influent and effluent concentrations between 
the plants sampled (Figure 2.2). Based on the mean influent concentrations Plants B, C, I-b and 
H were significantly different from Plant E (p=<0.001, 0.010, <0.001, <0.001). While Plants D, 
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F, and G were significantly different from Plants B (p=0.001, 0.002, 0.020) and H (p=0.002, 
0.003, 0.030). Plants A and I-a were not significantly different from any of the plants sampled. 
Plant B had the highest influent concentration of E2 at 28.02 ng/L while Plant E had the lowest 
concentration (8.71 ng/L).  
Effluent concentrations of E2 at Plants A vs I-a, H vs I-b, B vs G, and C vs D were not 
statistically different from each other (p>0.05). E2 concentrations in the effluent from Plants A 
and I-a were statistically higher than the concentrations measured in effluent from Plants E 
(p<0.001). Concentrations measured at Plants B, G, H, and I-b were statistically different from 
Plant E (p=0.006, 0.012, <0.001, <0.001) but not different from Plants A (p=0.522, 0.365, 1.000, 
1.000) and I-a (p=0.332, 0.211, 0.999, 0.995). Concentrations from Plants C and D were 
statistically different from concentration measured at Plants A (p=<0.001, 0.004) and I-a 
(p=<0.001, 0.002) but not from Plant E (p=0.995, 0.600). Plant F however was only statistically 
different from Plant A and I-a. Plant A had the highest concentration of E2 in the effluent (5.41 
ng/L) while Plant E had the lowest concentration (1.22 ng/L). However, Plant C had the greatest 






Figure 2. 2 Mean estradiol (E2) concentrations in influent and effluent from various 
wastewater treatment plants.  Estradiol concentrations were measured in influent (striped) and 
effluent (solid) samples from various WWTPs. The log concentration along with standard error 
was plotted to show the difference between the samples from each site. Significant differences 
between influent and effluent concentrations were found at all plants sampled (*). Significant 
differences in influent concentrations between plants are indicated using upper case letters, while 
differences in effluent concentrations are shown using lower case letters. 
E1 concentrations ranged from 42 to 104 ng/L in influent and 0.7 to 52 ng/L in effluent. 
This compound had the most varied percent difference across the different plants sampled, with -
3% difference at Plant I-a to 98% difference at Plants C and D (Table 2.9). E1 concentrations 
were significantly different between influent and effluent samples at all plants (p<0.001) except 
plants F (p=0.090) and I-a (p=0.961) (Figure 2.3). Influent E1 concentrations at Plants A, C, H, 
and I-b were not statistically different from each other (p>0.05), however they were statistically 
higher than concentrations measured at Plant G (p=0.002, 0.014, <0.001, 0.001). Plants B, D, E, 
F, and I-b were not statistically different from each other or from any of the other plants 
(p>0.05). E1 concentrations in the effluent sampled varied significantly between the plants. 
Plants C, D, E, and G were not statistically different (p=1.000) with concentrations of E1 around 
1 ng/L. However, the concentrations at these plants were statistically different from all other 
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plants sampled at which had concentrations above 5 ng/L (p<0.05). Plant I-a had a statistically 
different concentration of E1 in the effluent compared to all other plants (p<0.05) except for 
Plant A (p=0.743) and Plant F (p=0.690), which were also not statistically different from Plants 
B, H, and I-b (p>0.200).  
 
Figure 2. 3 Mean estrone (E1) concentrations in influent and effluent from various 
wastewater treatment plants. Estrone concentrations were measured in influent (striped) and 
effluent (solid) samples from various WWTPs. The log concentration along with standard error 
was plotted to show the difference between the sample from each site. Significant differences 
(p<0.05) between influent and effluent concentrations from the different WWTPs are indicated 
by *. Significant differences in influent concentrations between plants are indicated using upper 
case letters, while differences in effluent concentrations are shown using lower case letters. 
As predicted E3 concentrations in influent (91 – 395 ng/L) and effluent (0 – 7 ng/L) 
(Figure 2.4) were significantly different at all plants sampled (p<0.001). This compound had the 
greatest and most significant percent difference between influent and effluent samples, with over 
95% across all treatment plants sampled. Influent concentrations were found to be significantly 
different between plants. Plant H was significantly different from Plants D (p<0.001), E 
(p=0.003), and F (p=0.018). Plants B, C, and I-b were significantly different from Plant D 
(p=0.003, 0.031, 0.011), but not Plants E (p= 0.068, 0.353, 0.180) and F (p=0.288, 0.353,0.552). 
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Influent concentrations at Plants A, G, and I-a were not significantly different from any of the 
plants sampled (p>0.05).  
Patterns of E3 effluent concentrations are much more variable and unpredictable. Plant I-
a was statistically different from all other plants sampled, with no E3 measured in the effluent 
samples collected (p<0.020).  Plants A and D had statistically different concentrations of E3 in 
the effluent compared to Plants F (p<0.001) and H (p<0.001). Concentrations found at Plants B 
and C are not significantly different (p=1.000).  
 
Figure 2. 4 Mean estriol (E3) concentrations in influent and effluent from various 
wastewater treatment plants. Estriol concentrations were measured in influent (striped) and 
effluent (solid) samples from various WWTPs. The log concentration along with standard error 
was plotted to show the difference between the sample from each site. Significant differences 
(p<0.05) between influent and effluent concentrations from the different WWTPs are indicated 
by *. Significant differences in influent concentrations between plants are indicated using upper 
case letters, while differences in effluent concentrations are shown using lower case letters. 
For EE2 there was no significant difference between influent (0.3-7 ng/L) and effluent 
(0.7-5 ng/L) concentrations at plants A-E and I-a (p > 0.05), however significant differences 
were detected at plants F, G, H, and I-b (p < 0.001) (Figure 2.5). At plants G and H, the influent 
concentrations were below the detection limit of 0.5 ng/L, whereas at Plant I-b the influent 
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concentrations were significantly lower than effluent concentrations but still within the detection 
limit. At Plant F, the effluent concentration was significantly lower than influent concentrations. 
Influent EE2 concentrations at Plants G, H and I-b were not significantly different from 
each other (p>0.05), however they are statistically different from all other plants sampled 
(p<0.001). EE2 concentrations from Plants C and F were not significantly different from each 
other but were significantly different from Plants A (p=0.011, 0.015), G (p<0.001), H (p<0.001), 
and I-b (p<0.001).  
Effluent concentrations at Plants B and D were not significantly different from any of the 
other plants sampled(p>0.05). Plants A, H, I-b were only significantly different from Plants C 
(p=0.025, 0.023, 0.034), E (p=0.020, 0.018, 0.027), F (p<0.001), which had lower concentrations 
of EE2. Plants C and E were not different from Plants G (p=0.396, 0.346) and I-a (p=0.364, 








Figure 2. 5 Mean ethinyl estradiol (EE2) concentrations in influent and effluent from 
various wastewater treatment plants. Ethinyl estradiol concentrations were measured in 
influent (striped) and effluent (solid) samples from various WWTPs. The log concentration along 
with standard error was plotted to show the difference between the sample from each site. 
Significant differences (p<0.05) between influent and effluent concentrations from the different 
WWTPs are indicated by *. Significant differences in influent concentrations between plants are 
indicated using upper case letters, while differences in effluent concentrations are shown using 
lower case letters. 
Percent reductions ranged from 19-100% post treatment at all WWTPs, expect Plant I-a 
which had a 3% increase in E1 concentrations and an 81% increase in EE2, and a 88% increase 
in 2018 (Table 2.5). E3 had the highest and most consistent percent reduction across all 
treatment plants, however the reduction at plant F was significantly different (One-way ANOVA, 
p<0.05) to the other plants analyzed. EE2 had the lowest reduction with no significant 
differences between plants. EE2 was below the detection limit in the influent from Plants G and 
H, therefore an accurate percent reduction could not be determined. E2 and E1 had the most 
variable reductions in concentrations between plants. Although reductions were variable at most 
plants, Plant C had consistently high reductions of all the natural estrogens, while one of the 
lowest reductions of EE2.  
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Table 2.9 Percent reduction of estrogen concentration at various wastewater treatment 
plants. Percent reduction was calculated using the measured estrogen concentrations in influent 
and effluent samples from the various WWTPs. Statistical differences in reduction between the 
plants for each estrogen measured is shown using superscripts (p<0.05). 
WWTP 
Percent difference (%) 
E2 E1 E3 EE2 
A 68 ab 51 ab 99 18 
B 89 a 87 ab 100 29 
C 92 a 98 a 99 15 
D 81 ab 98 a 99 7 
E 86 ab 97 ab 99 39 
F 78 ab 52 ab 95 a 37 
G 76 ab 93 ab 99 - 
H 84 ab 91 ab 99 - 
I-a 62 b -3 b 100 -81 
I-b 83 ab 93 ab 99 -88 
 
 The total estrogenicity (E2 equivalency) was calculated for each sample using the 
individual estrogen concentrations and the E2 equivalency factor proposed by Arlos et al. (2018) 
for each estrogen.  The percent composition of the total calculated estrogen concentration and 
total calculated estrogenicity for influent and effluent are shown in Figure 2.6 and Figure 2.7 
respectively.  
The total estrogen concentration in influent samples ranged from 200 to 500 ng/L (Table 
2.10). A consistent trend in the composition of the influent was found across all treatment plants, 
as shown in Figure 2.6(A). The total estrogen concentration in influent samples was composed of 
over 50% E3, followed by E1, E2, and less than 5% EE2. The calculated influent estrogenicity 
ranged from 20-70 ng/L E2eq (Table 2.10). Although E3 was a major contributor to influent 
estrogen concentration, it has less than a 30% contribution to the total estrogenicity of the 




Figure 2. 6 Percent composition of total estrogen concentration (A) and total 
estrogenicity(B) in influent samples from various Ontario wastewater treatment. The 
concentration of E1, E2, E3, and EE2 were measured in influent samples and summed to 
determine the total estrogen concentration. The percent of individual estrogen in the total 




Table 2. 10 Total estrogen concentration and total estrogenicity of influent samples  
WWTP 
Total estrogen concentration 
(ng/L) 
Calculated Total Estrogenicity 
(ng/L E2eq) 
A 313.58 60.7 
B 364.64 53.8 
C 320.20 48.5 
D 148.49 28.7 
E 158.19 22.3 
F 206.39 30.1 
G 214.11 21.6 
H 524.74 69.3 
I-a 281.87 35.5 
I-b 376.55 63.7 
 
 The total estrogen concentration of effluent samples ranged from 4 to 63 ng/L (Table 
2.11). Unlike the influent samples, the composition of the effluent was not uniform across the 
different treatment plants (Figure 2.7 (A)). E3 accounted for less than 30% of the total 
concentration despite being the largest component of influent, therefore the drop in total 
concentration can be attributed to the efficient reduction of E3. At plants A, B, F, H and I E1 was 
the biggest contributor, while E2 was the largest contributor of concentration at plants C, D, and 
E. At plant G, EE2 was the largest contributor of concentration. The total calculated 
estrogenicity of these effluent samples ranged from 2 to 27 ng/L E2eq (Table 2.11). Similar to 
the influent samples, E3 was the smallest contributor to estrogenicity, accounting for less than 
5% of the total estrogenicity of the effluent samples across all the plants sampled. E1 accounted 
for a small portion of the total estrogenicity at plants C, D, E, G, H, and I-b. Plants A, B, F, and 
I-a had greater contributions from E1, which correlates with the higher proportion of E1 in the 
effluent samples at these sites and the higher total estrogen concentrations. E2 and EE2 are the 
largest contributors to the total estrogenicity of the effluent from plants B, C, D, E, G, H, and I-b, 




Figure 2. 7 Percent composition of total estrogen concentration (A) and total 
estrogenicity(B) in effluent samples from various Ontario wastewater treatment plants. 
The concentration of E1, E2, E3, and EE2 were measured in effluent samples and summed to 
determine the total estrogen concentration. The percent of individual estrogen in the total 





Table 2. 11 Total estrogen concentration and total estrogenicity of effluent samples 
WWTP 
Total estrogen concentration 
(ng/L) 
Calculated Total Estrogenicity 
(ng/L E2eq) 
A 62.95 26.60 
B 11.89 6.65 
C 5.18 3.38 
D 5.47 4.36 
E 4.29 2.94 
F 28.37 8.88 
G 10.60 8.41 
H 23.30 13.26 
I-a 52.28 21.89 




The total estrogenicity of the various WWTP samples was measured using a Yeast 
Estrogen Screen assay (YES). Initial estrogenicity in the influent ranged between 5-14 ng/L E2eq 
with no significant difference between plants (p>0.05). After treatment, estrogenicity was 
significantly (p<0.05) reduced to levels between 0.25-12 ng/L E2eq (Figure 2.5). However, the 
total estrogenicity of the influent was not significantly different from that of the effluent at plants 
A, F, and I-a (Two-way ANOVA, p<0.05). The reduction of estrogenicity at these plants was 
less than 20% while the other plants were achieving reductions greater than 80%, except Plant B 
which only had a 55% decrease (Appendix 4). Similar to the results in pharmaceuticals and 
estrogen concentration reduction, Plant C had the highest reduction of total estrogenicity (93%). 
Sampling of Plant I over two years shows a drastic difference. In 2017 there was a 23% increase 




Figure 2. 8 Mean total estrogenicity (based on YES) of influent and effluent from various 
wastewater treatment plants. Total estrogenicity of the influent and effluent samples was 
measured using the YES assay and expressed as estrogenicity relative to E2. This data is plotted 
with standard error to show the difference in estrogenicity before and after treatment. Significant 
differences in estrogenicity of influent and effluent from the different WWTPs are indicated with 
*.  
 
 Compared to the calculated total estrogenicity of the influent and effluent samples (Table 
2.10, Table 2.11), the measured total estrogenicity was significantly lower (p= <0.001, 0.001). 
The total estrogenicity determined using both techniques were plotted to determine if there was a 
positive correlation between the methods (Figure 2.9). Total estrogenicity of influent samples 
had poor correlation (R=0.49) with chemical measurements while effluent samples had a higher 





Figure 2. 9 Calculated and measured total estrogenicity from various Ontario wastewater 
treatment plants.  Calculated total estrogenicity was determined using the concentrations and 
E2 EEQ factor of E1, E2, E3, and EE2. Measured total estrogenicity was determined by running 




Although all treatment plants sampled (A, B, E, F, G, H, I) operated using conventional 
activated sludge they varied greatly in size and operation (Table 2.1). Plants C and D were very 
small plants operated as an aerated lagoon (510 m3/s) and oxidation ditch (1,040 m3/s), 
respectively. All the plants would be classified as secondary treatment, which meets Canadian 
regulatory requirements. Conventional activated sludge (CAS) systems are biological processes 
that aerate the wastewater to reduce organic matter and produce flocculate sludge. This 
flocculate is a heterogenous mix of microorganisms which changes continuously in response to 
the composition of the wastewater and environmental changes (Ramalho 1983). This sludge is 
recycled and added to new wastewater influent to promote increased biological degradation of 
contaminants. Extended aeration (Plant I), and oxidation ditch (Plant D) are modifications of 
CAS systems, and typically have longer residence times and reduced the need for sludge 
handling, which is better suited for smaller scale plants (Ramalho 1983). Aerated lagoons (Plant 
C) also have longer residence times, however are not CAS systems as they are flow through 
systems with no recycling of sludge.  
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All the plants sampled were below the regulations for effluent total suspended solids 
(TSS) of 25 mg/L. Regulations also require effluent to have less than 25 mg/L of carbonaceous 
biochemical oxygen demand (CBOD), which is a subset of biological oxygen demand (BOD). 
Effluent from all plants were measuring below 9 mg/L BOD and therefore met the requirements 
outlined. Of the nine treatment plants sampled, only four plants (Plants A, B, C, D) were 
required to nitrify according to their COA. Of these plants, Plants A and B were above the 
CCME guidelines for un-ionized ammonia (0.019 mg/L). Despite being required to have 
nitrification by its C of A, Plant A only had 89% removal of ammonia. Plant F only had 53% 
removal of ammonia and consequently had the highest concentration of un-ionized ammonia. 
Therefore, this plant is expected to have the poorest effluent quality. The new Wastewater 
Systems Effluent Regulations state that effluent discharged from WWTPs must not exceed 1.25 
mg/L of un-ionized ammonia at 15°C ± 1°C when they come into force in 2021. The removal of 
ammonia is a critical parameter for wastewater treatment as it has been associated with acute 
toxicity. In addition, it has been shown although there is not direct causal link established there 
appears to a relationship between nitrification and the removal of key pharmaceuticals and 
estrogen (Achermann et al. 2018).   
Removal of pharmaceuticals by various WWTPs has been widely studied in recent years. 
Due to the wide range of structures and chemical properties of pharmaceuticals, removal and 
degradation of these compounds varies greatly among WWTPs (Clara et al. 2004). In a similar 
way, the concentration and apparent removal of different pharmaceuticals varied considerably 
among the plants included in the present study in Ontario.  
Some select pharmaceuticals (e.g. atrazine (ATRZ), carbamazepine (CBZ)) were not 
detected in influent samples but were quantifiable in effluent or had increased concentrations in 
effluent compared to the corresponding influent samples. This has been reported in other studies 
and can be a result of several factors (Clara et al. 2004; Behera et al. 2011). Some compounds 
are excreted in their inactive conjugate forms which can become deconjugated by 
microorganisms during the treatment processes (Tran et al. 2018). The method used for this 
study only extracted unconjugated compounds, therefore influent concentrations could be 
underestimated since conjugated compounds are missed. The deconjugation of compounds that 
are not easily removed can increase effluent concentrations above influent levels. Another 
possibility is that compounds can be absorbed or entrapped in particulate matter as the samples 
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are filter through a 1 µm filter prior to extraction. Although these compounds will not be 
detected in the influent, throughout the treatment process the compounds can be released back 
into the aqueous phase and therefore detected in the final effluent. The detection of compounds 
in effluent and not influent could also be a result of the matrix and detection limits. Influent is a 
dirtier sample, making detection of compounds more difficult compared to in effluent samples 
which should be cleaner.  
Several representative compounds were selected for further discussion (e.g. CBZ, VEN, 
IBU, NPX) due to their specific characteristics. CBZ and VEN have been characterized as 
persistent pharmaceutical that are difficult to remove using traditional wastewater treatment 
processes, suggesting that influent and effluent concentrations of these compounds should 
remain fairly consistent (Tran & Gin 2017). Therefore, these compounds can be used to account 
for environmental changes such as increased flow due to rainfall (e.g. dilution). IBU and NPX 
are compounds that are easily removed or degraded, therefore the presence of these compounds 
in final effluent can be used as an indicator of poor treatment at the WWTPs.  
Concentrations of CBZ in influent and final effluent were not significantly different at six 
of the ten WWTPs sampled, with an increase in concentration in the final effluent at all plants 
except C which had a 67% reduction. This minimal change in concentration was expected due to 
its well-known persistence of CBZ during biological degradation and low octanol/water partition 
coefficient (Kow <4.00) (Tran & Gin 2017). There was a was a statistically significant increase of 
CBZ at Plants F and I-(a/b).  An increase in pharmaceutical concentration between influent and 
effluent has previously been documented at wastewater treatment plants and can be a result of 
the factors mentioned above. Plant C was the only WWTP to see a significant reduction in CBZ 
concentration post treatment. VEN is another compound characterized as being persistent 
throughout biological treatment processes, with reductions ranging from -5 to 98%. Similar to 
CBZ, it was also found to have significantly different concentrations in influent and effluent at 
Plant C (98% reduction) and in Plant G (38% reduction). Plant C is the only treatment plant that 
used an aerated lagoon. Aerated lagoons, with extended solids retention times (SRT) have been 
previously demonstrated to be effective removal of pharmaceuticals (Metcalfe et al. 2003; Li et 
al. 2013). 
As expected, a significant difference in IBU was measured between influent and effluent 
samples at all WWTPs with no difference in effluent concentrations among any of the plants. 
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IBU has a low sorption coefficient and is easily degraded when nitrification is applied (Joss et al. 
2004). This matches the nutrient data collected from these samples, which shows that Plants A-E 
and G-I were achieving over 80% total nitrogen removal. Plant F had the lowest IBU difference 
between influent and effluent which corresponds to its low nitrogen removal. NPX 
concentrations in influent and effluent were significantly different at all WWTPs sampled. NPX 
is a compound that is easily removed due to its molecular structure, therefore it is not surprising 
that plants with secondary treatment are able to significantly reduce the concentration.  There 
was a slight difference in IBU (98% to 100%) and NPX (99% to 100%) concentrations in Plant I 
sampled at different times (2017, 2018). This correlates with an improvement seen at the plant in 
terms of improved TKN removal, increasing from 89% to 97%, and supports the relationship 
between increased nitrification and increased pharmaceutical degradation (Joss et al. 2004). 
All WWTPs were sampled during dry weather and what was reported as normal operation. 
The stable nature of CBZ and the similar concentration in influent and effluent suggests that 
there were no major external factors influencing the wastewater (dilution, etc.). Other than Plant 
F which had low ammonia removal and correspondingly lower removal of the pharmaceuticals 
measured, indicating poor treatment, the high degradation of IBU and NPX at all other plants 
sampled indicate that the treatment plants are operating efficiently. This was further supported by 
the effective removal of other endpoints such as TSS and COD/BOD.  
In general, the influent concentrations of estrogens greatly depend on the treatment plant 
and the type of influent the treatment plants were receiving. Influent concentrations of E1, E2, 
and E3 at Plants D, E, F, and G were similar (not significantly different) while Plants A, B, C, H, 
and I were also similar to each other. Concentrations of EE2 entering these plants however was 
very unpredictable. Despite all the treatment plants sampled operating with secondary treatment, 
there was significant variability in the estrogen concentrations in final effluent and percent 
reduction (difference) among the nine treatment plants.  
Several recent studies have looked at the concentrations of estrogens in influent and 
effluent samples from various types of WWTPs as summarized in Table 2.12. The values of E1, 
E2, and EE2 found in influent and effluent samples fall in the current study in Ontario fall within 
range of other studies that have been reported. However, very high concentrations of E3 were 
found in influent samples compared to other studies. Discrepancies between the range of influent 
and effluent concentrations measured can be attributed to sampling location or sampling 
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methods. Baronti et al. (2000) and Johnson et al. (2000) measured concentrations in European 
WWTPs which have different collection and treatment plant configurations (although similar 
processes) as well as different regulations on effluent discharge compared to Canadian WWTPs. 
Sampling method can also impact the concentrations of estrogens measured. Grab samples give 
an immediate snap shot of what is in the sample at that specific time point with the samples 
being preserved immediately. However, when collecting composite samples, collection is done 
over a 24 h period and samples are not preserved until after the sample was collected. This could 
lead to degradation and biotransformation during the sample collection period.    
Table 2. 12 Range of estrogen concentrations in influent and effluent samples from 
previous studies 
  Estrogen Concentration Range (ng/L) 
Source Sample Type E1 E2 E3 EE2 
Servos et al. 
(2005) 
Influent 19-78 2.4-26 - - 
Effluent 1-96 0.2-14.7 - - 
Baronti et al. 
(2000) 
Influent 25-132 4-25 24-188 0.4-13 
Effluent 3.3-82.1 0.4-3.3 0.43-18 0 – 1.1 
Johnson et al. 
(2000) 
Influent <0.5 – 140 <0.5 – 48 2-120 <0.2 – 10 
Effluent <0.5 - 54 <0.5 - 12 <0.5-28 <0.2 – 4.5 
Fernandez et 
al. (2007) 
Influent 0-33 0-11 0-22 0-2 
Effluent 8-56 0-158 0-29 0-178 
This Study 
Influent 10-100 8-28 90-400 0.3-7 
Effluent 0.7-52 1-6 0-7 0.7-5 
 
As expected, there was a significant difference in E2 and E3 concentrations between 
influent and effluent at all WWTPs sampled. These plants all utilize aerobic processes, which 
promotes the oxidation of E2 to E1 (Ternes et al. 1999), resulting in the reduction of E2 but an 
increase in E1 concentrations. This could explain why no significant difference in E1 
concentration was measured at Plants F and I-a. In addition to the increased concentration as a 
result of biotransformation, conjugated E1 compounds not detected in the influent sample could 
have become deconjugated during the treatment process, offsetting the reduction of the initial 
concentration measured in the influent sample. E1 concentrations in influent and effluent from 
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Plant A were significantly different but were not different from concentrations found at Plants F 
and I-a. Although the influent and effluent concentrations of E2 were significantly different at 
each plant, Plants A, F, and I-a had the lowest percent difference in concentration. These are also 
the plants with the highest residual ammonia and TKN in the final effluent (suggesting poor 
treatment).  
E1 and E2 have increased removal when there is good nitrification being applied to the 
influent. Estrogen removal does seem to be related to activity of ammonia oxidizing bacterium 
(AOB) (Ren et al. 2007). However, other recent studies have found that there is no direct link to 
nitrifying activity (Achermann et al. 2018). Out of all the plants sampled Plants A, F, and I-a had 
less than 90% removal of TKN, indicating poorer nitrification. These plants also had slightly 
lower percent differences in IBU and NPX between influent and effluent. The lower level of 
nitrogen removal can be attributed to a lower activity of AOB in the activated sludge. Nitrifying 
conditions apparently also promote the activity of bacteria/conditions that may be responsible for 
the removal of estrogen. This may explain why the E1 concentrations in the final effluent of the 
poorly operating plants were not different from the final effluent and there was also a lower 
percent apparent removal of E2 concentration in these plants. E1 is further converted to E3 
which is the least hydrophobic of the four estrogens measured, making it the more accessible for 
degradation. There was over a 95% difference between E3 concentrations in influent and effluent 
at all plants sampled, which is the highest and most consistent difference among the different 
estrogens. Unlike the other estrogens, the main degradation pathway for E3 is via direct use as an 
electron donor for heterotrophs which are readily found in CAS systems (Ren et al. 2007).  
EE2 had the lowest apparent removal (i.e. percent difference; <40%) between influent 
and effluent samples across all the plants. Significant differences were found at plants G, H, and 
I-b, however these differences were a result of increased effluent concentrations. Plant F had the 
only significant decrease in EE2 concentrations, however this plant had the poorest treatment of 
pharmaceuticals and nutrients. EE2 is more metabolically stable than the naturally produced 
estrogens (Shi et al. 2004; Ren et al. 2007). Ternes et al. (1999) had found that there was no 
significant reduction in EE2 concentration in activated sludge batch reactions and that despite the 
higher Kow, sorption did not play a big role in their experiments. Batch experiments with 
nitrifying activated sludge have shown that the enzyme ammonium monooxygenase produced by 
AOB (or related bacteria) may co-metabolize EE2 resulting in the hydroxylation of the 
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compound (Shi et al. 2004; Vader et al. 2000). This produces a hydrophilic degradation product 
that has been shown to be non-estrogenic (Vader et al. 2000). These experiments however were 
conducted with initial concentrations of EE2 that are above concentrations measured in influent 
samples and are performed for individual compounds. Vader et al. (2000) showed a 50% 
decrease in EE2 (initial concentration of 50 µg/L) after 25 hours, while Shi et al. (2004) showed 
a 50% decrease from a concentration of 1 mg/L after approximately 20 hours. EE2 was found at 
concentrations around 10 ng/L in influent and is the smallest contributor to the total estrogens. 
Conditions that promote AOB (and related bacteria) will lead to the removal of ammonia, and 
possibly other estrogens, or the various other pharmaceuticals and hormones found in 
wastewater. Therefore, the degradation of EE2 may be enhanced by conditions that promote 
AOB (even if they are not directly responsible) and longer SRTs.  
 Although EE2 is poorly treated in the CAS systems studied in this study in Ontario, EE2 
is a synthetic hormone and is not produced as a by product during the treatment process so the 
increased effluent concentrations at Plants G, H, I-a, and I-b may be a result of deconjugation 
and/or incomplete extraction techniques. This study was designed to measure the concentration 
of free estrogens, however it is possible that most of the EE2 in the influent at these plants was in 
the conjugated form and not accounted for during the extraction, which under estimates the 
concentrations. The conjugated EE2 could have become deconjugated throughout the treatment 
process and then detected in the final effluent. Another possibility is that as the extraction of 
estrogens used the same method for both influent and effluent samples, much dirtier influent 
samples could cause overloading of the cartridges. This can lead to the breakthrough of estrogens 
in the sample (differently from the surrogate spikes) through the cartridges resulting in the 
underestimation of the influent concentration.  
Characterizing the change in composition of estrogens after treatment provided some 
indication of which estrogens were more persistent than others. The ratio of estrogens in the raw 
influent didn’t vary between treatment plants which was surprising considering the major sources 
of organic load varied between the WWTPs. Natural estrogens are excreted in their conjugated 
forms by men and women, with excretion rates ranging from 1.8-550 µg/d E1, 1-395 µg/d of E2, 
and a maximum of 64 µg/d of E3 (Johnson & Williams 2004; Ternes et al. 1999). Birth control 
pills are the major contributors to EE2 in influent and are excreted at an average rate of 11.3 µg/d 
(Johnson & Williams 2004). Therefore, the expected ratio of estrogens is E1>E2>E3>EE2 in raw 
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influent. Although the major estrogens excreted are E1 and E2, E3 has the greatest presence in 
raw influent as a result of the biotransformation of E1 and E2 into E3 (Ternes et al. 1999). 
Taking biotransformation into consideration, the excretion rates are consistent with the ratios of 
estrogens found in the raw influent.  
Comparing the ratio of estrogens in the influent to the effluent, there is a shift in the 
estrogen composition that varies among plants. The removal efficiencies for E3, E2, E1, and EE2 
decrease in that order (Ben et al. 2017; Johnson & Sumpter 2001). Based on the removal 
efficiencies it would be expected that EE2 and E1 would be the biggest contributors to the total 
estrogen concentration (E1, E2, E3, EE2), however this is dependent on the level of treatment 
applied at the various plants. Fernandez et al. (2007) found E1>E2>E3 to have the greatest 
concentration of estrogen in final effluent with EE2 concentration ranging widely between 
plants. This is similar to the results found in the present study.  
Aligning with the removal efficiencies and the degradation pathway of E3, it contributes 
the least to the total estrogen concentration in the final effluent and has an even smaller 
contribution to the total estrogenicity of the sample. Effluents from Plants A, F, and I-a were 
mainly composed of E1, with E1 being the major contributor to total estrogenicity. As discussed 
earlier, these plants had lower levels of nitrification, which could result in inefficient removal of 
E1. Plants B, H, and I-b had similar effluent compositions. These plants had higher levels of 
calculated total estrogenicity, which is proportional to the higher concentrations of total 
estrogens in the effluent. Plants C, D, E, and G had similar effluent compositions. A larger 
proportion of the effluent was composed of E2 and EE2 which were also the largest contributors 
to total estrogenicity as expected, as E2 and EE2 are the more potent estrogens. These four plants 
range in treatment processes from lagoons, oxidation ditches to conventional activated sludge.  
Based on the concentrations and EEQ of E1, E2, E3, and EE2, the calculated total 
estrogenicity of influent samples ranged from 20 to 70 ng/L E2eq. However, the total 
estrogenicity measured using the YES assay had significantly lower results, ranging from 5 to 14 
ng/L (p<0.001). This was not expected since the YES assay is performed using whole sample 
extracts and contains additional weakly estrogenic compounds that are not accounted for in the 
calculated total estrogenicity (Yu & Chu 2009). Unlike Fernandez et al. (2007) who showed a 
positive trend between calculated and measured total estrogenicity of the samples, the calculated 
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total estrogenicity did not follow a similar trend to the measured estrogenicity and had poor 
correlation (R=0.48).  
The calculated total estrogenicity of the final effluent ranged from 2 to 27 ng/L E2eq, 
whereas the measured estrogenicity using the YES assay ranged from 0.2 to 12 ng/L E2eq. These 
two sets of values had a positive correlation (R=0.90) and were more similar than influent 
samples. These effluent samples also had significantly lower measured total estrogenicity than 
what was predicted from the estrogen concentrations (p = 0.001). The discrepancies between the 
calculated and measured total estrogenicity of the samples can be attributed to several factors. 
Firstly, the YES assay is conducted with whole sample extracts. Wastewater samples, especially 
influent, are very dirty and contain a variety of compounds such as anti-estrogens (Beresford et 
al. 2000) such as BPA (Fernandez et al. 2007) which could inhibit the estrogen receptors in the 
assay. There are also compounds found in both influent and effluent which can be toxic to yeast 
from various pathways, for example triclosan (Yu & Chu 2009), which can prevent the growth 
and result in a lower response on the YES assay. On the other hand, the calculated total 
estrogenicity is only based on the concentrations of the four extracted compounds, so it doesn’t 
account for the interaction of other components of wastewater. Since influent samples are dirtier 
and more loaded with contaminants than effluent samples the inhibitory affects could be 
amplified in the influent YES assay. Although a serial dilution is used to dilute the influent 
before exposure to the cells, the toxicity of the sample could lead to inhibitions in cell growth. 
Although cell density is accounted for when calculating the response, a low cell density would 
not give accurate results and therefore underestimate the total toxicity since viable cells are 
needed for this assay.  Calculated and measured effluent total estrogenicity values were much 
closer because the effluent is treated, and it is expected to be cleaner than influent (possibly 
removing some of the interfering compounds). The YES assay also indicated a significant 
decrease in total estrogenicity at all WWTPs except Plants A, F, and I-a, which was expected as 
these were the plants that had low percent apparent removal (differences between influent and 
effluent concentrations) as well as poorer ammonia and %TKN removal.  
In conclusion, the results from the analysis of influent and effluent from nine secondary 
WWTPs in southern Ontario show that certain pharmaceuticals can be used as indicators of 
treatment and changes to the treatment process. Recalcitrant compounds such as CBZ and VEN 
can be used to assess seasonal flow changes while highly treatable compounds such as IBU and 
56 
 
NPX can be indicators of efficient treatment processes. Analysis of estrogens in influent and 
effluent supported the importance of efficient nitrification and longer SRTs in the reduction of 
these compounds. As expected E2 and E3 had significant differences (i.e. reductions) between 
influent and effluent. E1 varied between plants and was more dependent on treatment processes, 
while EE2 had very little difference across the treatment plants. Overall the total estrogenicity of 
the influent was decreased significantly when there was over 90% removal of TKN. Although 
the total estrogenicity is reduced, the final effluent discharged into surface waters has a larger 
proportion of EE2, the more persistent and potent estrogen.  
Despite these secondary treatment plants meeting the current regulations (with the 
exception of Plants A, B, F, and I-a for unionized ammonia), there was not complete removal of 
environmental contaminants of concern. Meeting these standards does have a positive impact on 
the treatment of most of these compounds and reduces the total estrogenicity of the final effluent. 
However, low but detectable concentrations of estrogens and estrogenicity remain especially for 
the more recalcitrant EE2. Plants with poorer treatment processes, as indicated by the lower 
removal of nitrogen and more treatable pharmaceuticals, also do not readily remove all the 
estrogens or total estrogenicity. It demonstrates the importance of continuously aiming to 
achieve improved treatment standards to ensure the reduction of a contaminants to minimize 







Chapter 3 – Tracking effluent quality changes associated with 
upgrades at two Canadian WWTPs (Kitchener and Waterloo) 
 
Emerging contaminants are a big concern as these compounds are always changing with 
time and are typically not targeted by traditional wastewater treatment plants (WWTPs). 
Compounds such as pharmaceuticals and personal care products as well as endocrine disrupting 
compounds have been detected in effluent discharged from WWTPs and have been linked to 
adverse impacts on fish downstream of these discharge sites (Gunatilake et al. 2016; Fuzzen et 
al. 2015; Vega-Morales et al. 2013; Kidd et al. 2007). Improving treatment plants for the 
removal of these compounds across Canada could cost billions of dollars. A better understanding 
of the behaviour of these compounds in wastewater treatment plants is therefore needed. 
High concentrations of pharmaceuticals and estrogenic hormones have been detected in 
effluent discharged from the two largest WWTPs in the Grand River watershed (Kitchener and 
Waterloo). Both plants have undergone major upgrades to improve the quality of effluent 
discharged, specifically targeting improving nitrification to decrease ammonia concentrations. 
Upgrades have continued at the Kitchener plant since 2012, and the Waterloo WWTP began 
major upgrades in 2017. Studies on fish in the Grand River have shown that the upgrades at the 
Kitchener WWTP in 2012 have led to a reduction in intersex (Hicks et al. 2017) and steroid 
responses (Marjan et al. 2018). The upgrades have resulted in a decline in total estrogenicity of 
the effluent discharged since 2012 (based on YES). Unfortunately, there was no data for 
individual estrogen concentrations as a reliable method was not available, however a limited 
number of samples were archived with surrogate spikes. This presented the unique opportunity to 
document the changes at the two WWTPs over time. Using achieved samples (since 2010) and 
new collections (2017 and 2018) specific estrogens (EE2, E2, E1) are determined in the final 
effluents of Kitchener and Waterloo.  This is compared to measurement of effluent quality, 
pharmaceuticals and total estrogenicity overtime.  
3.1 Method 
Grab samples were collected in 1 L amber glass bottles just before the outfall at the 
Waterloo WWTP and before UV disinfection at the Kitchener WWTP. These samples were 
preserved, extracted, and analyzed for hormones, total estrogenicity, and pharmaceuticals as 
outlined in Chapter 2.1. In addition to these analyses, the final effluent was collected to 
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determine nutrient levels. Although these samples were not collected as part of a planned 
monitoring program they were collected and analysed under the same or very similar protocols 
over time. The timing of the samples is therefore not regular as they were collected for other 
purposes but were all spiked with surrogate standards before being stored at -20°C.  
3.1.1 Nutrients  
Nutrient analysis of the final effluent at the Kitchener and Waterloo WWTPs were done 
by Maxxam Labs (Waterloo, Ontario). Grab effluent samples were collected in 250 mL in high 
density polyethylene (HDPE) bottles with 1 mL of 49% sulfuric acid as a preservative for the 
analysis of ammonia, nitrate, and nitrite. Grab effluent samples were collected in 250 mL HDPE 
bottles with no preservatives for the analysis of dissolved chloride and conductivity. Effluent 
nutrient quality parameters were measured by a third party, Maxxam Analytics using the 
approved methods listed in Table 3.1. 
Table 3. 1 Effluent nutrient analysis methods 




Nitrate (NO3) SM 4500 NO3-I Colourimetry 0.50 mg/L 
Nitrite (NO2) SM4500 NO2-B Colourimetry 0.010 mg/L 
Total Ammonia - N EPA GS I-2522-90 m Colourimetry 0.05 mg/L 
Conductivity SM 23 2510 m  Conductivity Meter  1.0 umho/cm 
Dissolved Chloride (Cl-) EPA 325.2 m Automated Colourimetry  6.0 mg/L 
 
In addition, the Region of Waterloo provided effluent quality data for the duration of the study 
period at Kitchener and Waterloo. 
 
3.1.2 Kitchener and Waterloo WWTP Upgrades 
 
The Kitchener WWTP was initially designed with two plants in the early 1960s to mid-
1970s. As of 2007 the treatment process involved flow through four primary clarifiers which is 
then split between two plants for ferrous chloride injection and aeration. Secondary clarifiers 
were used for settling. Effluent was disinfected with sodium hypochlorite before being 
discharged into the Grand River. In 2010 dechlorination was implemented. The largest process 
changes started in 2012 with upgrades to a fine bubble aeration system to introduce partial 
nitrification in Plant 1 and full nitrification in Plant 2 (Table 3.2). UV disinfection replaced 
chlorination as a disinfection technique. In 2015 the construction of Plant 3 and 4 began. These 
plants are designed to provide full nitrification and tertiary treatment for advanced phosphorous 
removal and will eventually replace Plant 1. In addition, Plant 2 received return activated sludge. 
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In 2016 a new outfall to the Grand River was commissioned followed by tertiary filters in 2017. 
However, wastewater flowing through Plant 1 is not currently being filtered and is only partially 
nitrifying. As a result, the effluent discharged from the outfall is a mixture of effluent receiving 
varying levels of treatment.  
Table 3. 2 Summary of Kitchener WWTP upgrades since 2012 (Pam Law, Region of 
Waterloo) 
Upgrade Description Commissioning Date 
New aeration – Plant 1(new diffusers/blowers, but not fully 
nitrifying) 
October 2012 
New tanks/aeration – Plant 2 – Pass 1 August 2012 
New tanks/aeration – Plant 2 – Passes 2 and 3 January 2013 
New Outfall November 2016 
Tertiary Filters Commissioned (Plant 1 not being filtered) August 2017 
Optimized coagulant dose for TP control  October 2017 
Plant 3 online  
Plant 4 online  
Plant 1 offline  
 
The Waterloo WWTP is a conventional activated sludge system. Wastewater goes 
through primary clarifiers before entering aeration cells with mechanical aerators. Ferrous 
chloride was the added for phosphorous removal before going through final clarifies and being 
disinfected using sodium hypochlorite. Effluent from this plant is discharged into the Grand 
River. From 2009 to 2014 the WWTP began receiving centrate which was high in ammonia from 
the biosolids dewatering system. In 2012 UV disinfection was commissioned to replace chlorine 
disinfection. In 2014 upgrades to primary and secondary treatment were initiated. 
In March 2017 aeration tank 1 was upgraded and in March 2018 a second aeration tank was 
brought online, providing year-round nitrification (Table 3.3).  
Table 3. 3 Summary of Waterloo WWTP upgrades since 2009 (Pam Law, Region of 
Waterloo) 
Upgrade Description Commissioning Date 
Interim Dewatering (note: centrate sent to the Raw Sewage PS, 
aeration upgrades not completed, so temporary increase in 
effluent ammonia) 
2009 – 2014 
RAS re-aeration online  
Aeration tank 1 upgrades March 2017 






3.2.1 Nutrients  
Between 2010 and 2018 both the Kitchener and Waterloo WWTP effluents have 
observed decreases in ammonia concentrations in their final effluent discharged and 
subsequently an increase in nitrate concentrations. Kitchener effluent was measuring above 20 
mg/L of ammonia prior to 2012 at which time there was a major drop in concentration (10 mg/L) 
(Figure. 3.1) that corresponds with the implementation of major plant upgrades. The ammonia 
concentrations continued to decrease after the beginning of 2013 and generally remained below 5 
mg/L. During the continuation of plant construction there were several treatment upsets. In mid-
2014 there was a large spike in ammonia concentrations suggesting a major change in treatment 
operation and effectiveness (Figure 3.2). Daily flow at the Kitchener WWTP have been 
relatively consistent since 2007, with yearly peaks corresponding to increases in flow due to 
snow and rain events (Figure 3.3).  This shows that when the first treatment upgrades occurred in 
2012 (increased aeration) there was an improvement (based on ammonia removal) although 





Figure 3.1 Select nutrients in final effluent grab samples from the Kitchener WWTP. 
Ammonia, nitrite, and nitrate concentrations were measured in effluent grab samples from 
Kitchener since 2010. Upgrades occurred at this plant in the fall of 2012 and are indicated on the 




Figure 3. 2 Weekly ammonia concentrations in final effluent from the Kitchener WWTP 





Figure 3. 3 Daily Flow at the Kitchener WWTP (provided by Pam Law, Region of 
Waterloo)   
 
The Waterloo WWTP experienced a similar trend to Kitchener after the upgrades with a 
reduction in ammonia concentrations and increase in nitrate concentrations being observed, 
beginning in 2016 (Figure 3.4).  Grab samples were analyzed since mid-2011 and analysis of 
these samples indicate a gradual decrease in initially high levels of ammonia. However, analysis 
of weekly effluent data from 2007 (Figure 3.5) reveals that prior to 2011 ammonia levels were 
generally well below 20 mg/L and progressively increased, reaching the highest concentrations 
of ammonia in 2012-2013. Daily flow at the Waterloo WWTP shows relatively consistent flows 
since 2007 with yearly peaks corresponding to increases in flow due to snow and rain events 
(Figure 3.6). This suggest that there was a reduced treatment effectiveness during construction 





Figure 3. 4 Select nutrients in final effluent grab samples from the Waterloo WWTP. 
Ammonia, nitrite, and nitrate concentrations were measured in effluent grab samples from 
Waterloo since 2011. Major upgrades occurred at this plant in the fall of 2017 and are indicated 





Figure 3. 5 Daily ammonia concentrations in final effluent from the Waterloo WWTP (data 





Figure 3. 6 Daily Flow at the Waterloo WWTP (provided by Pam Law) 
 
3.2.2 Pharmaceuticals  
Select pharmaceuticals (Table A2.1) have been monitored in the final effluent from the 
Kitchener and Waterloo WWTPs since 2010, however on the basis of the results from Chapter 2, 
CBZ, VEN, IBU, and NPX were used to characterize the effluent quality over time. The 
Kitchener WWTP began upgrades in the fall of 2012, therefore samples collected between 
November 2010 to July 2012 were used to determine a pre-upgrade mean and 95% confidence 
interval for each compound (Table 3.4). CBZ and VEN concentrations remain close to pre-
upgrade levels following the upgrades (Figure 3.7 (A, B)). Some variation is observed in the 
CBZ and VEN concentrations over the years, bringing it outside of the 95% confidence interval. 
IBU and NPX concentrations show significant decreases in concentrations post upgrades (Figure 
3.7 (C, D)).  
The Waterloo WWTP implemented significant upgrades in the fall of 2017, so samples 
from August 2015 to August 2017 were used to determine a pre-upgrade mean and 95% 
confidence interval (Table 3.2). As shown in Figure 3.8 (A, B) CBZ and VEN concentrations in 
final effluent from Waterloo remain unchanged post upgrades. In contrast, IBU and NPX 
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concentrations have significantly decreased since the upgrades were implemented (Figure 3.8 (C, 
D)). Analysis of these compounds also shows fluctuations in concentrations which follow the 
fluctuations in ammonia concentrations.  
 
Table 3. 4 Pre-upgrade mean and 95% confidence intervals of select pharmaceuticals and 
estrogens in the final effluent from the Kitchener and Waterloo WWTPs 
 Concentration (ng/L) ± 95% Confidence 
Pharmaceuticals CBZ VEN IBU NPX 
Kitchener WWTP 619 ± 1580 1631 ± 997 3538 ± 41 2537 ± 131 
Waterloo WWTP 560 ± 226 678 ± 73 950 ± 308 828 ± 400 
Hormones E1 E2 EE2  
Kitchener WWTP 47.1 ± 12.5 6.4 ± 2.0 5.8 ± 6.6  






Figure 3. 7 Concentrations of carbamazepine (A), venlafaxine (B), naproxen (C), and ibuprofen (D) measured in final effluent 
grab samples from Kitchener WWTP over time. Concentrations of select pharmaceuticals (ng/L) in final effluent grab samples 
from Kitchener and standard error are plotted along with the corresponding ammonia concentrations (mg/L). The solid line indicates 
the pre-upgrade mean calculated using the samples indicated with black bars. The dotted lines are the 95% confidence intervals for the 






Figure 3. 8 Concentrations of carbamazepine (A), venlafaxine (B), naproxen (C), and ibuprofen (D) measured in final effluent 
grab samples from Waterloo WWTP over time. Concentrations of select pharmaceuticals (ng/L) in final effluent grab samples from 
Kitchener and standard error are plotted along with the corresponding ammonia concentrations (mg/L). The solid red line indicates the 
pre-upgrade mean calculated using the samples indicated with black bars (during a period of poor operation prior to the major 




Concentrations of estrogens (E1, E2, EE2) have also been measured in final effluent grab 
samples from the Kitchener and Waterloo WWTPs since 2010. As done for the pharmaceuticals 
the 95% confidence intervals were calculated for each plant immediately prior to the major 
upgrades, e.g. 2012 Kitchener and 2017 Waterloo (Table 3.4). Samples collected for this study 
were only included in the analysis if specific criteria were met. These criteria include good 
QA/QC recoveries, appropriate qualifier ion ratios and retention times, and consistent peak area 
for the internal standard spiked into each sample analyzed. Recoveries for the QA/QC samples 
were required to be ± 20% of the expected 20 µg/L. Qualifier ion ratios and retention times are 
compound specific and were determined using estrogen standards during method development. 
Finally, the peak area of the internal standard was observed and required to maintain ± 20% of 
the peak area between samples and QA/QC samples throughout the analysis. All samples used 
for this study met all of these requirements to ensure proper extraction, analysis, and compound 
quantification and qualification.  
At the Kitchener WWTP E2 concentrations showed a significant decrease post upgrades, 
however there were periods of elevated results (Figure 3.9 (A)). In early 2013, E2 concentrations 
were back to pre-upgrade levels, while in the summer of 2014 and 2015 concentrations were 
much higher than pre-upgrade concentrations. A drop in E1 concentrations was also observed 
over the years post-upgrade, however there was a spike in Aug 2014, brining concentrations back 
to pre-upgrade levels (Figure 3.9 (B)). Like E2, increases in E1 concentrations were also seen in 
2013 and 2015, however these concentrations were still lower than the pre-upgrade 
concentration.  
E2 concentrations at the Waterloo WWTP began to decrease just after the upgrades in fall 
2017, however they increased back to pre-upgrade concentrations in August 2018 (Figure 3.10 
(A)). A similar response was observed in E1 concentrations (Figure 3.10 (B)), however further 
sample collection and analysis is needed post-upgrade to determine if this was an upset/event or 
a trend.  
As shown in Figure 3.9 (C) and Figure 3.10 (C), concentrations of EE2 at both the 
Kitchener and Waterloo WWTPs remain unchanged post upgrades. Final effluent concentrations 
have been below 5 ng/L, except for major spikes observed in 2012 and 2014 when the 
concentration of EE2 ranged from 50-120 ng/L.  
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Figure 3. 9 Concentrations of E2 (A), E1 (B), and EE2 (C) in final effluent grab samples 
from the Kitchener WWTP over time. Estrogen concentrations in effluent grab samples have 
been analyzed since 2011in Kitchener and plotted with standard error. To determine if 
concentrations have changed since upgrades were implemented, a pre-upgrade mean (solid line) 
was calculated from samples collected pre-upgrade (black samples). The 95% confidence 
interval for this mean is indicated by the dotted line. Samples indicated with * are above the 






Figure 3. 10 Concentrations of E2 (A), E1 (B), and EE2 (C) in final effluent grab samples 
from the Waterloo WWTP over time. Estrogen concentrations in effluent grab samples have 
been analyzed since 2014 in Waterloo and plotted with standard error. To determine if 
concentrations have changed since upgrades were implemented, a pre-upgrade mean (solid line) 
was calculated from samples collected pre-upgrade (black samples). The 95% confidence 
interval for this mean is indicated by the dotted line. Samples indicated with * are above the 





The total estrogenicity of final effluent grab samples from Kitchener and Waterloo were 
measured using the YES assay since 2009/2010. This assay determines the estrogenicity of the 
whole matrix, considering all of the various components that can bind to the estrogen receptor. 
Post-upgrades at Kitchener a significant reduction of total estrogenicity has been found in the 
final effluent (Figure 3.11). Concentrations are outside the 95% confidence interval of the pre-
upgrade average. Although the estrogenicity has been reduced, spikes were detected in the 
summer and fall of 2014 with concentrations equivalent to pre-upgrade conditions.    
 
Figure 3. 11 Total estrogenicity measured in final effluent grab samples from the Kitchener 
WWTP over time. Total estrogenicity of final effluent grab samples from Kitchener were 
measured using the YES assay since 2010. The average estrogenicity was plotted with the 
standard error. The average pre-upgrade estrogenicity was calculated using samples from 2 years 
prior to the upgrades, indicated in black. The solid line indicates the pre-upgrade average total 
estrogenicity with the 95% confidence interval indicated by the dotted lines.  
Over time at the Waterloo WWTP the total estrogenicity of the final effluent has been 
highly variable. Major upgrades were implemented in the fall of 2017 and therefore samples 
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from two years prior to the upgrade were used to determine a pre-upgrade mean. Several samples 
from 2014 measured very highly estrogenicity, with concentrations greater than 10 ng/L E2eq 
(Figure 3.12). However, effluent grab samples analyzed post upgrades do not fall outside the 
95% confidence interval of the pre-upgrade average.  
 
Figure 3. 12 Total estrogenicity measured in final effluent from the Waterloo WWTP over 
time. Total estrogenicity of final effluent grab samples from Waterloo were measured using the 
YES assay since 2009. The average estrogenicity was plotted with the standard error. The 
average pre-upgrade estrogenicity was calculated using samples from 2 years prior to the 
upgrades, indicated in black. The solid line indicates the pre-upgrade average total estrogenicity 
with the 95% confidence interval indicated by the dotted lines.  
 
3.3 Discussion  
The main focus of the upgrades at both the Kitchener and Waterloo WWTPs was to 
implement full nitrification to address concerns of water quality in the receiving environment 
and to address emerging regulatory requirements. The upgrades to date have shown to be 
successful, with increased removal of ammonia and other parameters. A major decrease in 
ammonia concentration and corresponding increase in nitrate was observed in 2012 at the 
Kitchener WWTP corresponding with the upgrades to the aeration system that introduced 
improved nitrification. The spike in ammonia concentrations in 2014 correlates with various 
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upsets documented at the plant. At Waterloo, the centrate from the biosolids dewatering 
introduced to the wastewater treatment plant was high in ammonia. This resulted in the 
temporary increase in final effluent ammonia concentrations seen in Figure 3.4. The decrease in 
ammonia concentrations in the final effluent beginning in 2017 indicates improvements to 
treatment process and increased nitrification. This corresponds with the upgrades and 
installments of the aeration tanks. Through the analysis of ammonia/nitrate at these two plants 
during the upgrade process, it is evident that ammonia (and nitrate) levels are a good indicator of 
treatment (e.g. nitrification). Improved treatment at the plants can be seen by the decreased 
concentrations of ammonia, and the times of treatment upsets are reflected by increased 
ammonia concentrations.  
Although the upgrades at these two plants being designed to improve traditional effluent 
quality targets such as those in the Wastewater Effluent Systems Regulation (outlined in Chapter 
1.1.1), studies have found that improving nitrification and extending solid retention time (SRT) 
can indirectly improve the removal of various micropollutants (Achermann et al. 2018, Metcalfe 
et al. 2003; Servos et al. 2005). CBZ and VEN are recalcitrant compounds that can be used as 
indicators of external factors that can influence treatment and concentration while IBU and NPX 
can be used to indicate the effectiveness of the treatment applied during the treatment process 
(Chapter 2). At both the Kitchener and Waterloo WWTPs the final effluent CBZ concentration 
remained relatively consistent throughout the years and a similar pattern was seen with VEN 
concentrations. The slight fluctuations in the concentrations seen between November and April 
of each year correspond with fluctuations in flow at the plants (Figure 3.3, 3.6) and are most 
likely due to snow melt and rain events.  
IBU concentrations in the effluent from the Kitchener WWTP have significantly 
decreased since the upgrades in the fall of 2012 when additional aeration (i.e. nitrification) was 
introduced. At the Waterloo WWTP a significant decrease in effluent IBU concentration also 
occurred once nitrification was implemented in 2017. NPX concentrations have also significantly 
decreased since the implementation of nitrification at both plants, however unlike IBU it is 
influenced more by the treatment level. IBU is very responsive to treatment however, NPX 
concentrations had a stronger correlation to increases in ammonia concentrations compared to 
IBU. A similar observation was made by Joss et al. (2005). Both of these compounds increased 
in concentration at the Kitchener WWTP in 2014 when there was a spike in ammonia 
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concentrations. Overall, the significant decrease in both IBU and NPX final effluent 
concentrations over time at the Kitchener WWTP highlights the effectiveness of the new 
treatment processes being utilized.  
Although the upgrades at both the Kitchener and Waterloo WWTPs have had a 
significant impact on the reduction of ammonia concentrations and select pharmaceuticals from 
the final effluent being discharged into the Grand River, the removal of estrogens remains more 
complex and ambiguous. When interpreting estrogen concentrations, it is important to consider 
two factors that can strongly influence the measurements: conjugation and biotransformation 
(including into other estrogens).  
With the upgrades at Kitchener (2012) and Waterloo (2017), significant reductions in E2 
and E1 concentrations in the final effluent were observed. The concentrations of E2 were 
consistently lower than those of E1 which was expected because of their high removal 
efficiencies and the biotransformation of E2 to E1 under aerobic conditions (Ternes et al. 1999) 
(further explained in Chapter 2). Overall, the patterns in E2 and E1 concentrations follow the 
fluctuations in ammonia concentrations similar to the indicator compounds ibuprofen and 
naproxen. However, spikes in concentration of E2 and E1 were seen at similar time points for 
both these compounds at the Kitchener WWTP, which followed a large increase in ammonia 
(Dec 2012, March 2014, May 2015). These fluctuations indicate issues with the nitrification and 
possibly a disturbance to the nitrifying conditions (and related bacteria) found in the sludge. A 
relationship has been previously reported between degradation of micropollutants and ammonia 
oxidizing bacteria (AOB) (Chapter 2) but the degradation does not appear to be directly related 
to the AOB but rather to the conditions that enhance nitrification as well as solids retention time 
(SRT) (Achermann et al. 2018). Servos et al. (2005) also reported that wastewater plants in 
Canada with longer SRT had higher apparent removal of estrogens (E2, E1). After an upset the 
bacteria may need time to recover back to their full abundance/activity to be able to degrade 
estrogens. Arlos et al. (2018) estimated influent concentrations of E1 and E2 at the Kitchener 
WWTP to be 37 ± 5 ng/L and 17± 2 ng/L, while at Waterloo they were 32 ± 7 ng/L and 13 ± 3 
ng/L. The spikes in E1 and E2 at both plants fall below the predicted influent range and are not 
unreasonable concentrations if there was poor treatment. E3 was not measured over time at the 
Kitchener and Waterloo WWTPs. In eight Ontario treatment plants, 95% removal of E3 was 
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observed (Chapter 2). E3 concentrations in final effluent have been reported to be very low in a 
variety of other studies (Fernandez et al. 2007; Johnson et al. 2002; Baronti et al.) 
Unlike the natural estrogens, EE2 concentrations are very low in influent (as shown in 
Chapter 2), therefore concentrations in final effluent are also low and remain below 5 ng/L post 
upgrades, with no obvious trends. This aligns with the findings of other studies (Table 2.12) and 
is expected because of its higher stability and low removal efficiency (Ternes et al. 1999).  
With the introduction of nitrification, there was a decrease in total estrogenicity at the 
Kitchener and Waterloo WWTPs. Total estrogenicity is a measure of the cumulative estrogenic 
impacts of the components in the final effluent, so a decrease was expected as there was a 
decrease in several estrogenic compounds measured (e.g. E1, E2). There can also be other 
estrogenic compounds in the effluent, such as alkyphenols, but the effects directed assessment 
(EDA) reported by Arlos et al. (2018) indicated that the natural estrogens along with EE2 explain 
most of the estrogenicity in the Kitchener effluent.  The YES assay data (total estrogenicity) also 
generally follow the patterns of estrogen concentration measured by mass spectrometry. 
However, they tend to be lower than that predicted during major upsets by the analytical 
chemistry and application of equivalency factors (see Chapter 2). This could be a result of the 
presence of anti-estrogens or other compounds which could be inhibiting the YES, especially in 
poorly treated effluent (Buckley et al. 2010; Ihara et al. 2014). 
Although there was no apparent decrease in EE2 concentrations post upgrades at either 
plant, some anomalies/inconsistencies in the results (2012, 2014) have led to questions about the 
estimated concentrations that need further study.  The concentrations of EE2 in final effluent 
samples (post-upgrades) were typically below 2 ng/L which is similar to other report in the 
literature (Table chapter 2).  However, there was an elevation in the apparent effluent EE2 
concentrations ranging from 25 ng/L to 130 ng/L during the months of June to October of 2014 
at both WWTPs. The same samples had a corresponding increase in total estrogenicity (YES), 
however to a much lower extent than what would be expected based on the chemically detected 
estrogen concentrations. It is possible that the matrix inferred with the YES assay and 
underestimated the total estrogenicity. Based on the concentrations of E1, E2, and EE2 found in 
those samples, a YES assay response at approximately 150 ng/L EEQ was expected, whereas the 
biologically measured estrogenicity peaked at 32 ng/L EEQ.  The value of 130 ng/L of EE2 (150 
ng/L total EEQ) is much higher than what would be expected (but not impossible) based on the 
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literature and predictive models. Arlos et al. (2018) predicted that the concertation in influent 
would typically be less than 6 ng/L in these treatment plants but there are many factors that could 
alter this estimate. These differences could be related to artifacts of the methodologies and this 
methodological problem needs to be resolved to better understand the environmental exposure 
and biological implications of these chemicals. However, it is possible that some event occurred 
during the upgrades that led to elevated EE2 and estrogen values during these periods. 
This very high EE2 concentrations are not consistent with the biological responses in  
reported in downstream fish published by Hicks et al. (2017). Downstream of the Waterloo 
WWTP there were minimal changes in percent (%) incidence or severity of intersex between the 
years of 2007 and 2015 whereas a significant decrease in the % incidence and severity of 
intersex (testes-ova) was observed downstream the Kitchener WWTP post upgrades in 2012 
(Hickset al., 2017). However, with a spike in EE2 concentrations in the effluent over several 
months, an increase in incidence and severity might have been expected; although timing of 
exposure is also important, and the elevated exposure might have occurred outside of the 
sensitive development window. To further complicate the results, during the period of interest, 
there were no major upsets or spills reported at either and there are no significant changes in the 
weekly effluent quality measurements of total Kjeldahl nitrogen, phosphorous, suspended solids, 
or carbonaceous biochemical oxygen demand (5 day). However, just prior to these events of high 
EE2 concentrations, there were spikes in ammonia levels at both plants. It may have taken time 
for the biological community to re-establish. Despite the estrogen samples meeting all normal 
QA/QC these discrepancies raise the concern that the results obtained are biased in some way by 
analytical interferences. Although these elevated concentrations of EE2 are not typical effluent 
concentrations, they are not unheard of. Fernandez et al. (2007) also studied influent and effluent 
samples from Canadian WWTPs and reported measuring concentrations of up to 178 ng/L. 
Considering the importance of environmental estrogens in the responses observed in fish 
associated with wastewater outfalls, resolving these analytical issues and obtaining accurate 
measurements of their concentrations in wastewater is an important priority. Only 5 ng/L in an 
experimental lake led t o fish population collapse (Kidd et al. 2007) and Arlos et al (2018) 
suggested that estrogens at <20 ng/L could lead to severe intersex in fish in the Grand River. As 
most of the effluent extracts in the previous studies at the Kitchener and Waterloo WWTP are 
available the opportunity existed to re-examine these samples using alternate methods.   
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 Historical samples from Kitchener and Waterloo were re-analyzed using a more selective 
analytical approach, the LC-MS/MS QTOF, to try to determine whether the spikes measured on 
the LC-MS/MS QQQ were actually a result of EE2 or compounds analogous to EE2 (See 
Appendix B). Samples were also re-analyzed on the LC-MS/MS QQQ using a different 
quantification ion to determine whether a more compound specific fragment would be able to 
distinguish between EE2 and other components of the matrix (See Appendix B). Attempts to 
verify the original results were hampered by  the low remaining volumes of the historical 
samples. These additional analyses suggest that these historical samples most likely did have 
high concentrations of EE2, however several factors (e.g. very low concentrations, limited 
number of samples) still make it diffiuclt to completely rule out an analaytical issue. 
The reason for the high concentrations of EE2 at the Waterlooo WWTP can be a result of 
the on-going construction at the plant. EE2 sorption onto sludge in the wastewater system is both 
physical and chemical, however it is dominated by physical sorption (Xu et al. 2008). Therefore 
this reaction can easily be reversed and can have implication during the handling of sludge, 
specifically during dewatering (Matsui et al. 2000). Matsui et al. (2000) measured the total 
estrogenicity of samples from various points throughout a wastewater treatment plant and found 
that the filtrate post dewatering of the sludge had the highest total estrogenicity (474 ng/L E2 
equivalence), much greater than either effluent or influent levels.  
In 2009, the Waterloo WWTP began to receive centrate which was high in ammonia and 
caused a major spike in effluent ammonia concentrations. Since the dewatering process can 
release EE2 and other contaminants, it can be assumed that these compounds were also entering 
the WWTP at very high concentrations. Spikes in EE2 concentrations follow spikes in ammonia 
concentations in the effluent and appear to occur at points of seasonal changes. This could 
indicate issues with the bacteria culture in the activated sludge, due to weather changes, plant 
proceses (e.g. changes were made to the air supply in 2014), or possibly contaminant overload. 
There could be a delayed response in the estrogens, where the bacteria are not able to properly 
treat the increased concentrations of estrogens as they recover. In Chapter 2, it was shown that 
the total estrogenicity of the influent measured using the YES assay were muted compared to the 
chemically calculated values. Considering that dewatering centrate can be more estrogenic than 
influent and increase the effluent concentrations by a factor of nine (Yi & Harper 2007; Matsui et 
al. 2000), the YES assay may have understimated the effluent concentrations, as was reported in  
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Chapter 2. If this was the case, it would be expected that there would be an increase of other 
hydrophilic compounds with sorption coefficients (log KD) between 2 and 4 that would have 
increased in concentration during these time periods as well since compounds within this range 
can be removed by both degradation and sorption (Racz & Goel 2010). Compounds such as 
triclocarban, triclosan, fluoxetine, ibuprofen, and venlafaxine (Figure 3.8, Figure A6.2) had 
increases in concentration but not as evident as the estrogens. Although this could partially 
explain the occurrence at the Waterloo WWTP, the Kitchener WWTP is independent of the 
Waterloo plant but experienced spikes of EE2 in the same time period.  
Between 2012 and 2014 the Kitchener WWTP was undergoing major construction 
proceses, including the decommissioning of the lagoon, which involved transfer pumping the 
digested sludge. This involves a processes similar to dewatering and returning the centrate to the 
WWTP. However, contaminants bound to the sludge could have been released into the cenrate 
when the lagoon was being decommissioned. Both Kitchener and Waterloo experienced spikes 
in ammonia concentrations in March 2014 followed by increases in EE2 concentrations. 
Therefore it is possible there was a weather event impacting the bacteria culture at both plants, 
and resulted in poor treatment of the estrogens entering the system during the recovery period. 
As seen in Waterloo, there were similar changes in triclocarban, triclosan, fluoxetine, ibuprofen, 
venlafaxine (Figure 3.7, Figure A5.2), and in the total estrogenicity of the samples. 
Unfortunately, additional samples are not available to allow further analysis. 
In conclusion, the upgrades to the treatment processes at both the Kitchener and Waterloo 
WWTP have been significant in improving the overall quality of the effluent discharged into the 
Grand River. There have been notable decreases in ammonia, pharmaceutical concentrations and 
estrogen concentrations at both plants. The quantification of EE2 is difficult due to its low 
environmental concentrations and influence by matrix effects. However, although analytical 
artifacts can not be completely ruled out, detection of large concentrations of this compound is 
possible when there are upsets or major changes at the treatment plants high concentrations can 
occur; this is something to consider when studying treatment plants and may have implication of 





Chapter 4 – Conclusion and Recommendations 
 The analysis of influent and effluent from various WWTP has shown that despite all the 
plants in the study being classified as secondary treatment and meeting new regulations (with the 
exception of ammonia at some plants) they all had varying levels of effectiveness in regard to 
treating the influent for pharmaceuticals and estrogens. However, the improved treatment of 
select PPCPs, EDCs, and total estrogenicity with conditions that promoted nitrification (e.g. 
increased aeration) was apparent. The concentration and removal of select pharmaceuticals such 
as ibuprofen and naproxen can be used as indicators of effective treatment as they are easily 
degraded in those conditions. However, compounds such as carbamazepine and venlafaxine are 
very recalcitrant and remain untreated even with increased nitrification. Therefore, fluctuations 
in the concentrations of these compounds can be used as indicators of external factors 
influencing the treatment of PPCPs and EDCs.  
The treatment patterns of these pharmaceuticals and estrogenic hormones were also seen 
in the temporal study of the Kitchener and Waterloo WWTPs, both of which underwent major 
upgrades to their treatment processes. The upgrades were specifically intended to improve 
nitrification at both plants, which as shown in the first part of this study also fosters conditions to 
improve the removal of other contaminants of concern. These upgrades have resulted in 
decreased concentrations of ammonia, and many pharmaceuticals (e.g. ibuprofen, naproxen). As 
expected, compounds such as carbamazepine and venlafaxine remained unchanged post 
upgrades. 
 A major method of degradation of estrogens is through biotransformation which makes 
the quantification difficult as they get converted into different estrogens. The biotransformation 
can be influenced by the treatment processes applied and solid retention times causing variability 
among the different plants. Of the estrogens studied estriol had the highest removal whereas 17α-
ethinylestradiol had the poorest removal. Due to the consistently low concentrations of estriol in 
effluent samples, it was not measured at the Kitchener and Waterloo WWTPs. Estrone and 17β-
estradiol show decreases with improved nitrification at both plants. However, the upgrades show 
now impact on the concentration of 17α-ethinylestradiol measured at these plants. Despite this, 
there was a decrease in the total estrogenicity of the effluent discharged from the treatment plants 
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post upgrades. The estrogenicity of the effluent discharged is a combination of concentration and 
the potency of the compounds present in the effluent.  
The most estrogenic compound is 17α-ethinylestradiol and has impacts at low 
concentrations.  However very few studies are reporting significant concentrations of 17α-
ethinylestradiol which brings to question whether regulations are needed. Although these 
contaminants are not currently regulated, working towards achieving improved nitrification 
shows that it would continue to reduce the risk of PPCPs and EDCs on the environment. 
Some recommendations to consider are:  
1. Influent and effluent composite samples were handled (e.g. extraction) using the same 
methods, however influent samples are much dirtier and more concentrated compared to 
final effluent. Using the same extraction method may have led to loss of compounds or 
compromised the detection. It would be recommended to use either a smaller sample 
volume, sample clean up, or use tandem SPE columns to avoid these issues.  
2. Continued method development for estrogens, especially EE2 is recommended. A clean-
up method for estrogen samples should be developed for future analysis as it would result 
in clearer extracts with less potential matrix interferences. The 269 m/z fragement should 
be included in future EE2 analyis as it is more specific fragment and may potentially help 
to eliminate background in some samples. 
3. Influent samples may have a higher proportion of conjugated compounds which were not 
extracted or accounted for. Using an enzymatic deconjugation step prior to sampling can 
help account for all forms of compounds and give a more accurate representation of total 
concentrations. A study should be conducted to determine if conjugated estrogens are 
present in the influent and final effluent of treatment plants. 
4. The YES assay response to the influent composite samples resulted in lower than 
expected values. Influent samples are very dirty, and a sample clean-up step could help 
prevent over loading the yeast cells in the assay.  
5. An effects directed assessment of the effluent along with chemical measurement would 
be very informative. This would provide information on which compounds are causing 
the most impact and provide a better understanding between impact and concentration.  
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6. Lastly, when conducting studies on WWTPs it is important to not only consider the 
current conditions of the plant but the history of the plant as well. Like Kitchener and 
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Appendix A1: Analytes of Interest 
 
Table A1. 1 Chemical properties of the pharmaceuticals of interest 










IBU Ibuprofen NSAID C13H18O2 127.071 3.97 Negative 
BPA Bisphenol A Industrial C15H16O2 228.286 3.32 Negative 
NPX Naproxen NSAID C14H14O3 230.258 3.18 Negative 
GFZ Gemfibrozil Lipid regulator C15H22O3 250.332 4.77 Negative 
DCF Diclofenac NSAID C14H11Cl2NO2 296.148 4.51 Negative 
TCS Triclosan Antibacterial C12H7Cl3O2 289.541 4.76 Negative 
TCCB Triclocarban Antibacterial C13H9Cl3N2O 315.582 4.34 Negative 
ATRZ Atrazine Herbicide C8H14ClN5 215.683 2.61 Positive 
CBZ Carbamazepine Anti-epileptic C15H12N2O 236.258 2.45 Positive 
FLX Fluoxetine Antidepressant C17H18F3NO 309.326 4.05 Positive 
ATOR Atorvastatin Lipid regulator C33H35FN2O5 556.622 5.7 Positive 
VEN Venlafaxine Antidepressant C17H27NO2 277.401 3.2 Positive 
LIN Lincomycin Antibiotic C18H34N2O6S 406.535 0.2 Positive 
MON Monensin Antibiotic C36H62O11 670.866 5.43 Positive 
SULF Sulfamethoxazole Antibiotic C10H11N3O3S 253.276 0.89 Positive 




C16H16F3NO 295.299  - 
Positive 






















C33H34FN2O6 573.24 -  
Positive 
ACE Acetominophen Analgesic C8H9NO2 151.162 0.46 Positive 




C16H25NO2 263.374 2.72 
Positive 
 
Table A1. 2 Chemical properties of the hormones of interest 










4-NP 4-nonylphenol Industrial C15H24O 220.35 5.76 Negative 
4-OP 4-octylphenol Industrial C14H22O 206.323 - Negative 
BPA Bisphenol A Industrial C15H16O2 228.286 3.32 Negative 
E1 Estrone Estrogen C18H22O2 270.365 3.13 Negative 
E2 Estradiol Estrogen C18H24O2 272.381 4.01 Negative 
E3 Estriol Estrogen C18H24O3 288.38 2.45 Negative 
EE2 Ethynyl estradiol Estrogen C20H24O2 296.403 3.67 Negative 






















Table A1. 3 Chemical properties of the internal standards 





d3-IBU d3-Ibuprofen C13H15O2-d3 209.28 Negative 
4 NP – d4 d4-4-nonylphenol C15H20O-d4 216.35 Negative 
4 OP – d17 d17-4-n-octylphenol C14H5O-d17 223.323 Negative 
d3-NPX d3-Naproxen C14H11O3-d3 230.258 Negative 
d4--NPX d4-Naproxen C14H10O3-d4 234.258 Negative 
d14-BPA d14-Bisphenol A C15H2O2-d14 242.286 Negative 
BPA – d16 d16-Bisphenol A C15O2-d16 244.286 Negative 
d6-GFZ d6-Gemfibrozil C15H16O3-d6 256.332 Negative 
E1 – d4 
(new) 
d4-Estrone C18H18O2-d4 266.365 Negative 
E1 – d2 
(old) 
d2-Estrone C18H20O2-d2 268.365 Negative 
E2 – d4 d4-Estradiol C18H20O2-d4 268.381 Negative 
E3 – d2 
(new) 
d2-Estriol C18H22O3-d2 290.38 Negative 
E3 – d3 
(old) 
d3-Estriol C18H21O3-d3 291.38 Negative 
d3-TCS d3-Triclosan C12H4Cl3O2-d3 292.541 Negative 
d4-EE2 d4-Ethinylestradiol C20H20O2-d4 300.403 Negative 
d5-DCF d5-Diclofenac C14H6Cl2NO2-d5 301.148 Negative 
d2-TCCB d2-Triclocarban C13H7Cl3N2O-d2 317.582 Negative 
d-4-CP d4- Chlorophene   Negative 
d6-MET d6-metformin C4H5N5 135.164 Positive 
ACE Acetominophen C8H9NO2 151.162 Positive 
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d4-ACE d4- Acetominophen C8H5NO2-d4 155.162 Positive 
d3-CAFF d3-Caffeine C8H7N4O2-d3 197.19 Positive 
d5-ATRZ d5-Atrazine C8H9ClN5-d5 220.683 Positive 
d5-
Oxybenzone 
d5-Oxybenzone C14H7O3-d5 233.242 Positive 
d10-CBZ d10-Carbamazepine C15H2N2O-d10 246.258 Positive 




C15H2N2O2-d10 262.273 Positive 
d6-Desven d6-desvenlafaxine C16H19NO2-d6 269.374 Positive 
d7-ATEN d7-Atenolol C14H15N2O3-d7 273.335 Positive 
d4-SMZ d4-sulfamethazine C12H10N4O2S-d4 282.329 Positive 
d6-VEN d6-venlafaxine C17H21NO2-d6 283.401 Positive 
d3-TRIM d3-trimethoprim C14H15N4O3 293.317 Positive 
d5-NFLX d5-Norfluoxetine C16H11F3NO-d5 300.299 Positive 
d5-FLX d5-Fluoxetine C17H13F3NO-d5 314.326 Positive 
d3-LIN d3-lincomycin C18H31N2O6S 409.535 Positive 
d5-ATOR d5-Atorvastatin C33H30FN2O5-d5 561.622 Positive 
d5-p-ATOR d5-p-hydroxyl-atorvastatin C33H29FN2O6-d5 583.3106 Positive 




Appendix A2: YES Assay Reagents  
 
Table A2. 1 Yes assay reagent preparation 
Reagent Preparation Sterilization and Storage 
10x Yeast Nitrogen Base 
without Amino Acids  
67g YNB wo amino acids in 1L 
of MilliQ water  
0.2 µm filter sterilized  
4 C  
20% Dextrose Stock 700 mL MilliQ water 
200 g of dextrose added slowly 
to the milliQ while stirring  
brought up to 1L 
0.2 µmfilter sterilized  
4 C 
10mM copper sulfate solution 250 mg copper II sulfate 
pentahydrate in 100 mL MilliQ 
water 
0.2 µm filter sterilized  
Room temperature  
GOLD Concentration Stock 25 mL L-arginine-HCl, L-
methionine, L-isoleucine, L-
valine, L-threonine, L-tyrosine, 
L-phenylalanine, L-glutamic 
acid, L-aspartic acid, L-leucine 
and uracil 
 
50 mL of L-histidine-HCl, L-
serine and L-tryptophan 
 
75 mL of adenine sulfate 
 
100 mL of L-lysine-HCL 
 
0.2 µm filter sterilized  
4 C 
GOLD Media 60 mL 20% dextrose, 60 mL 
10X YNB wo AA, 110 mL 
GOLD concentrate, 370 mL 
MilliQ water 
0.2 µm filter sterilized  
4 C 
Minimal Media  100 mL 10X YNB wo AA, 100 
mL 20% dextrose, 10mL L-
lysine, 10 mL L-histidine, 78 
0.2 µm filter sterilized  
4 C 
Minimal Media Agar Plates  Autoclave 10 mL 10X YNB wo 
AA, 2 g bactoagar, 78mL MilliQ 
Cool to touch  
Add 1mL L-histidine, 1mL L-
lysine, 10 mL 20% dextrose 
Swirl to mix and pour into plates 
and cool to solidify at room 
temperature  


















Autoclave, 4℃ 4.0 g/L L-aspartic 
acid  
Autoclave, RT 
2.4 g/L L-arginine  Autoclave, 4℃ 18.0 g/L L-valine Autoclave, 4℃ 
2.4 g/L L-methionine Autoclave, 4℃ 24.0 g/L L-threonine  Autoclave, 4℃ 
0.9 g/L L-tyrosine  Autoclave, RT 45.0 g/L L-serine Autoclave, 4℃ 
3.6 g/L L-isoleucine  Autoclave, 4℃ 3.6 g/L L-leucine  Autoclave, RT 
3.6 g/L L-lysine-HCl Autoclave, 4℃ 4.8 g/L L-tryptophan  Filter, 4℃ 
3.0 g/L L-
phenyalanine  



































Appendix A3: Analytical Detection Limits  
 
Table A3. 1 Method detection limits of compounds of interest on the LC-MS/MS QQQ 
(McCann 2016) 
Analyte Surface water MDL (ng/L) Wastewater MDL (ng/L) 
Triclosan 11.2 56a 





Carbamazepine 1.54 10.8 
17α-ethinylestradiol  1 3.2 
17β-estradiol 0.5 3 
Estrone 1 4 
Estriol  1 3.6 
Gemfibrozil 3.3 16.5a 
Diclofenac 7.3 36.5a 
Ibuprofen 2.2 21.4 
Naproxen 2.6 16.4 
Fluoxetine 10.33 51.7a 
Venlafaxine 1.36 8.2 
Atorvastatin 8.2 41a 
p-hydroxy Atorvastatin 8.2 41a 
o-hydroxy Atorvastatin 8.2 41a 





Appendix A4: Influent and Effluent Data  
 




E3 E2 EE2 E1 
Site Influent Effluent Influent Effluent Influent Effluent Influent Effluent 
A 195.35 1.10 18.34 5.41 6.99 4.54 92.90 51.90 
B 285.74 1.29 28.02 2.96 2.05 1.46 48.83 6.18 
C 235.07 1.43 20.69 1.51 1.53 1.24 62.91 1.00 
D 91.58 1.05 10.02 1.87 2.04 1.82 44.86 0.72 
         
E 123.01 1.16 8.71 1.22 2.13 1.20 24.34 0.71 
F 151.57 6.49 10.52 2.12 1.88 0.69 42.41 19.07 
G 190.72 2.75 12.30 2.83 0.29 4.29 10.80 0.72 
H 394.82 4.84 25.97 4.28 0.32 4.93 103.63 9.25 
I-a 223.56 0.00 13.30 5.03 2.08 2.89 42.93 44.36 
I-b 255.49 3.69 24.78 4.07 2.53 4.28 93.76 6.54 
Average 214.69 2.38 17.27 3.13 2.18 2.73 56.74 14.05 
 
Table A4. 2 Standard error of estrogen concentrations in influent and effluent from various 
Ontario WWTP  
Standard Error 
 
E3 E2 EE2 E1 
Site Influent Effluent Influent Effluent Influent Effluent Influent Effluent 
A 4.86 0.69 0.82 0.10 1.25 0.60 5.20 0.58 
B 3.45 0.31 1.07 0.32 0.34 0.07 0.90 0.13 
C 2.34 0.81 0.51 0.27 0.31 0.14 2.52 0.35 
D 2.14 0.74 0.56 0.09 0.17 0.27 1.49 0.16 
E 2.66 0.29 0.39 0.25 0.48 0.17 1.25 0.24 
F 2.25 0.35 1.31 0.25 0.31 0.73 1.16 0.75 
G 9.69 0.47 0.42 0.19 0.00 0.26 0.20 0.10 
H 14.65 1.12 1.43 0.30 0.00 0.96 4.24 0.19 
I-a 5.09 0.00 0.96 0.38 0.49 0.31 2.48 0.32 











Table A4. 3 Total estrogenicity in influent and effluent composite samples from Ontario 
WWTPs 
WWTP 
Measured Total Estrogenicity (ng/L E2eq) 
Influent Effluent % Difference 
A 13.68  ± 1.08 11.78 ± 3.71 14 
B 7.25 ± 1.29 3.22 ± 0.39 55 
C 13.21 ± 2.19 0.30 ± 0.02 98 
D 5.74 ± 0.79 0.29 ± 0.04 95 
E 9.48 ± 1.02 2.32 ± 0.17 75 
F 6.59 ± 0.89 5.54 ± 0.60 16 
G 11.24 ± 5.71 0.88 ± 0.14 92 
H 9.86 ± 0.72 1.98 ± 0.09 80 
I-a 8.75 ± 2.04 10.74 ± 0.95 -23 














Appendix A5: Kitchener Additional Graphs Showing Full Range of Data 
 









Appendix A6: Waterloo Additional Graphs Showing Full Range of Data 
 
Figure A6. 1 EE2 concentrations measured in the effluent from the Waterloo WWTP over 
time 
 





Appendix B: Potential analytical uncertainty in the analysis of EE2  
 
B.1 Methods  
Ethinyl Estradiol is typically found in low concentrations (<1 ng/L) in the environment, 
making accurate identification and quantification difficult. Select effluent samples analyzed in 
Chapter 3 had measured concentrations greater than 20 ng/L of EE2 using the LC-MS/MS QQQ. 
Based on previous studies these concentrations are well above the normally expected 
concentration for final effluent samples. Samples had been extracted for estrogens using methods 
described in Chapter 1and stored at -20°C. Therefore, historical samples with high 
concentrations of EE2 were available and used for re-analysis using an Agilent 1200 series 
HPLC with an Agilent 6520 quadrupole time-of-flight (QTOF) mass spectrometer in negative-
mode ESI since the QTOF has increased selectivity to compounds compared to the QQQ. 
B.1.1 Ethinyl Estradiol - LC-MS/MS QTOF  
 The QTOF method was optimized by injecting concentrated standards of regular and 
deuterated EE2 onto an Agilent ZORBAX Eclipse Plus C18 (2.1 mm x 50 mm x 1.8 μm) HPLC 
column in full scan mode. Once the instrument was optimized for the compound, a calibration 
curve (10 µg/L to 3000 µg/L) was injected multiple times to determine the linearity and 
detection limit of the instrument. Following optimization of the standard, effluent samples seen 
to have high levels of matrix when analyzed on the QQQ were used to optimize the method to 
minimize the matrix effect. The method and mobile phase parameters are described in Table B.1 
and Table B.2.  
Table B. 1 LC-MS/MS QTOF Method Parameters 
Mass Spec Parameters 
MS Abs Threshold  500 MS Scan Rate (spectra/sec) 3.00 
MS/MS Abs Threshold  100 MS/MS Scan Rate (spectra/sec) 1.00 
Max Time between MS (sec) 0.0   
Source Parameters 
Gas Temp (℃) 300 Nebulizer (psig) 30 
Gas Flow (l/min) 10   
EE2 Parameters 
m/z  295.17041 Collision Energy (V) 45 
z 1 Detection Window (ppm) 20 
Quantifier Ion (m/z) 145.0659 Min Height (counts) 600 





Table B. 2 Estradiol LC-MS/MS QTOF Mobile Phase Parameters 
Mobile Phase A: 5mM Ammonium fluoride in MilliQ 
Mobile Phase B: 100% Acetonitrile 
Time (min) % Mobile Phase A % Mobile Phase B 
0 90 10 
10 0 100 
13 0 100 
13.10 90 10 
 
 Using the optimized method described in Table B.1, 10 µL of the hormone extracts were 
injected onto the column with the mobile phase gradient indicated in Table B.2 at a flow rate of 
300 µl/min. In addition, samples were injected as a sandwich injection, where 1µL of 500 µg/L 
EE2 was injected with 10 µl of the sample. A standard addition test was also performed to 
determine the impact of sample matrix on the accurate quantification of EE2. For this analysis a 
series of sandwich injections were done using a sample that had high background peaks and 
matrix, but no detected EE2 on the QQQ (Doon 2H – 15Sept17) and various concentrations of 
EE2 ranging from 0 – 100 000 µg/L.  
B.1.2 Ethinyl Estradiol - LC-MS/MS QQQ  
Historical samples analyzed on the QQQ were reanalyzed for EE2 using the method 
described in Chapter 2.1 with the additional transition of 296 m/z → 269 m/z. Samples as well as 
the calibration curve were quantified using two different methods. The first method used the 
fragment 145 m/z as the quantifier and the fragment 269 m/z was used as an additional qualifier 
ion. While the second method quantified EE2 using the 269 m/z fragment as the quantifier and 
145 m/z as a qualifier.   
B.2 Results & Discussion 
B.2.1 QTOF Method Validation  
Repeat injections of an EE2 standard and the calibration curve was used to determine the 
retention time and fragmentation patterns of the compound. The retention time of EE2 was found 
to be 6.03 minutes and is shown in Figure B.1. Injections of the calibration curve also allowed 
for the determination of the limit of detection (LOQ) on the QTOF. Figure B.2 demonstrates the 








Figure B. 2 EE2 calibration curve. The calibration points (n=3) were used to determine the 
linear range of EE2 on the QTOF. A 1/x weighting was applied since the effluent samples are 
expected to have concentrations at the lower end of the calibration curve.  
  
Key fragments produced by EE2, listed in Table B.3, have been identified by several 
studies (Croley et al. 2000; Magi et al. 2010). A full scan analysis of EE2 at various 
concentrations produced the fragment patterns seen in Figure B.3. Qualitative analysis of the 
mass spectrum produced shows that the parent ion of EE2 and the most common fragments can 
be identified when the concentration is greater than 10 µg/L. When the 10 µg/L calibration point 
was analyzed, no parent ion was detected and the only product ions of EE2 found were 143 m/z 
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and 145 m/z, the most abundant fragments of EE2. At higher concentrations, the mass accuracy 
of the parent ion was within 20ppm and a range of fragments were detected. The most abundant 
fragment was 145 m/z, while 143, 159, 199 and 183 m/z were similar in intensity. The 269 m/z 
fragment had the lowest intensity.  
Table B. 3 Common EE2 Fragments 
m/z Loss Product Ion 
295 - C20H24O2 
199 C6H8O C14H16O 
183 C7H12O C13H12O 
159 C9H12O C11H12O 
145 C10H14O C10H10O 
143 C10H16O C10H8O 
269 C2H2 C18H20O2 
 
 
Figure B. 3 EE2 calibration standard fragmentation patterns. A calibration curve with 
concentrations from 10-3000 µg/L was analyzed using a full scan method on MS/MS to 
determine the product ion ratios. In this figure the product ion spectrum for the concentrations of 
10 µg/L (A), 50 µg/L (B), 100 µg/L (C), and 200 µg/L (D) are shown. The parent ion is indicated 
by the blue diamond at 295 m/z.   
 
Although the parent ion was not detected in the 10 µg/L calibration point, the calibration 
curve was quantified with an accuracy of 80% or above when the 145 m/z fragment was used as 
the quantifier (Table B.4). However, the qualifier fragment of 159 m/z was not found for the 10 
µg/L point. The other fragments of EE2 were also difficult to detect in both the 10 and 50 µg/L 
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standards, which are environmentally relevant concentrations. The 143 m/z fragment had the 
highest abundance relative to the parent ion followed by 159, 183, and finally 269 m/z.  

















101 669 10 104 - - - 94 
50 2614 40 81 44 - 74 41 
100 5522 85 85 39 16 53 61 
200 13906 215 107 41 15 42 51 
500 41435 640 128 29 15 32 38 
3000 185669 2869 96 34 16 33 40 
1. N of 2 used. No EE2 detected in the sample. 
B.2.2 QTOF Sample Analysis 
The standard addition was performed to determine the affect of high matrix and 
background on the detection of EE2. A historical sample with high levels of background noise 
but no detectable EE2 was spiked with various concentrations of EE2. Compared to the expected 
concentration after spiking, the concentration of EE2 detected by the QTOF was consistently 
higher. Measured concentrations when spiked with 500 µg/L EE2 was off by 78%, but when the 
concentrations were increased, there was improved accuracy (Table B.5). It can be concluded 
that at higher concentration the matrix has minimal impact on the detection of EE2, however 
samples with lower concentrations (<20 µg/L) could be influenced and difficult to detect 
accurately. This becomes a problem because the environmentally relevant concentrations of EE2 
are below 20 µg/L.  




Expected Conc EE2 in 
Sample (µg/L) 
Conc EE2 Measured 
in Sample (µg/L) 
Percent Difference 
(%) 
0 0.0 0 0 
200 18.2 0 -100 
500 45.5 80.8 78 
1000 90.9 111.1 22 
2000 181.8 270.4 49 
5000 454.5 584.3 28 
10000 909.1 1075.1 18 
 
In addition, when comparing samples spiked with a high (10,000 ug/L) and low 
concentration (500 ug/L) spike of EE2, it clear that the mass accuracy was lost in the sample 
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with the low level spike (Figure B.4). When spiked with 10,000 ug/L EE2, the mass accuracy of 
the EE2 detected was -13.06 ppm off of the actual mass, within 20 ppm, whereas the mass of the 
parent ion in the low spike was -85.9 ppm off from the actual mass.  
 
 
Figure B. 4 Mass accuracy on QTOF in samples with EE2 spikes. Environmental samples 
were spiked with a high concentration of 10 000 ug/L EE2 (A) and low concentration of 500 
ug/L EE2 (B) to determine the mass accuracy of the parent ion detected by the QTOF when 
influenced by matrix.  
 
The qualification of EE2 in environmental samples was based on three factors, the correct 
retention time (6.00 ± 1.00 min), a detected mass to charge ratio (m/z) within 20 ppm of the 
expected value (295.17041 m/z), and the correct product fragment ratios. As described in 
Chapter 3, select grab effluent samples analyzed from the Kitchener and Waterloo WWTPs 
measured EE2 concentrations over 100 ng/L. These concentrations are much greater than most 
previously reported effluent concentrations, therefore these samples were selected and further 
analyzed using the QTOF to verify the identity of the compound being quantified using the QQQ 
method described in Chapter 2. Samples with low levels of EE2 were also analyzed on the 








Table B. 6 Comparison of EE2 quantification using an LC-MS/MS QQQ and QTOF 
Sample ID 
EE2 Concentration (µg/L) 
QQQ 
QTOF 
20 ppm 50 ppm 
Doon 12Oct29 78.9 9.3119 20.4465 
Doon 2 13Mar07  0 6.5812 6.4524 
Doon 1 13Jun07 0.1 No Peak  No Peak  
Doon 1 13Jul31 0.8 No Peak  3.7228 
Doon 14Jul24 25.9 No Peak  35.0307 
Doon 2 14Aug20 8.3 No Peak  9.9007 
Doon 3H 14Sept25 11.3 10.0444 11.6133 
Doon 2E 14Oct22 - 5.7656 5.75 
Doon 2H 14Oct22 10.3 12.6303 25.5573 
Doon 9H 15Jan21 - No Peak  7.5455 
Doon 1H 15Mar18 0 No Peak  No Peak  
Doon 2H 15Sept17 0.03 No Peak  No Peak  
Waterloo 2E 14Oct22 - 11.8693 19.1187 
Waterloo 1H 15Jan21 54.4 48.1087 51.6716 
Waterloo 2H 15Jan21 1.8 No Peak  5.8114 
Waterloo 1H 15Feb11 0.4 4.2582 8.4035 
When samples were analyzed on the QTOF peaks were quantified within a 20 ppm 
(295.1645 – 295.1763) and 50 ppm (295.1556 – 295.1852) range of EE2. Comparing the 
quantification results from the QQQ method to the QTOF showed very varied results. When 
analyzed using a 20 ppm restriction, many of the samples had no EE2 detected. These samples 
were ones that had low concentrations detected on the QQQ (<10 µg/L), except for the Doon 
14Jul24 sample which was quantified at 25.9 µg/L. When the range was widened to 50 ppm, 
which brings the selectivity of the QTOF close to the selectivity of the QQQ, a peak was 
detected and quantified at 35 µg/L. The Doon 12Oct29 sample showed much lower 
concentrations using the QTOF method, whereas the Doon 2H 14Oct22 and Waterloo 1H 
15Jan21 sample had similar concentrations using all methods.  
This indicated that despite the QTOF is more selective and mass accurate, it is more 
susceptible to matrix effect and the mass accuracy is lost at the lower concentrations. Therefore, 
although this shows that historical samples with high concentrations of EE2, possible have high 
concentrations, it can not be said with certainty due to the matrix effects. This method also might 
not be the most ideal method for analyzing environmental samples since concentrations are 
generally low and mass accuracy is lost at those concentrations.  
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B.2.3 QQQ Sample Analysis  
Historical samples with high concentrations of EE2 were re-run on the LC-MS/MS QQQ 
and quantified using a different transition to determine whether the instrument was detecting 
EE2 or a different compound. This was suggested by Ripolles et al. (2014) who found that the 
most intense fragment of EE2 (145 m/z) was found in the background and therefore resulted in 
increased results. The calibration curve and historical samples were quantifed using the 
fragments 145 m/z and 269 m/z to determine if there was a difference (Table B.7). Although the 
269 m/z fragment is less intense, analysis of the calibration curve shows that it can give an 
accurate measure of EE2.  
Comparisons of the samples between the two quantification methods shows that although 
there are some differences between the two methods, samples that had higher amounts of EE2 
detected using the 145 m/z method generally had high levels of EE2 when quantified using the 
269 m/z fragment as well.  




EE2 Concentration (µg/L) 














0 µg/L 0.00 0.79 
0.5 µg/L 0.39 1.01 
1 µg/L 0.76 1.36 
10 µg/L 8.29 7.89 
50 µg/L 27.63 27.44 
100 µg/L 95.98 94.37 
200 µg/L 194.23 195.37 













MS1-H July 7/15 21.91 22.75 
Spk Blank-H July 7/15 5.54 5.07 
Waterloo 2E_Oct24/14 1560.71 103.80 
Waterloo 1H Jan 21/15 30.51 47.86 
Waterloo 2H Jan 21/15 111.63 5.93 
Waterloo 1H Feb 11/15 0.49 1.37 
Waterloo Eff-1 Day 2 Aug 16/17 1.24 1.38 
Doon STP 1/3 Oct 29/12 21.76 21.17 
Doon 1 July 31/13 1.00 1.20 
Doon 2H Sep 25/14 27.40 10.90 
Doon 3H Sept 25/14 12.68 11.43 
Doon 2E Oct 22/14 28.00 9.55 
Doon 9H Jan 21/15 0.00 0.97 
Doon STP 1/3 Oct 29/12 22.14 20.33 
 
